Devices and methods for anchoring sleeve in tissue cavity
By using an anchoring system with negative pressure and an expandable sealing mechanism in the intestine, the challenges of delivering and anchoring medical devices in the intestine have been solved, achieving safe, reversible anchoring and fecal drainage, and reducing the complications of traditional ostomy.
Patent Information
- Application Number
- CN202380033658.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-18
- Filing Date
- 2023-04-18
- Publication Date
- 2024-11-26
AI Technical Summary
Delivery and anchoring of existing medical devices within tissue cavities and/or tubular tissue spaces present challenges, especially in the intestines. Traditional methods such as ostomy result in high morbidity and complications, and non-surgical fixation devices are difficult to anchor securely.
An anchoring system is employed, comprising a sleeve, an expandable sealing mechanism, and an open-cell foam. The system forms a seal with the intestinal wall through negative pressure and the expandable sealing mechanism, using the friction generated by the negative pressure for anchoring. The sleeve body provides support, avoiding surgical fixation.
It achieves safe, reversible, and non-invasive anchoring within the intestine, reduces complications, avoids the risks of traditional ostomy, and provides reliable fecal drainage and drug delivery capabilities.
Smart Images

Figure CN119031887A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Application No. 63 / 332,166, filed on April 18, 2022, the entire contents of which are incorporated herein by reference. Technical Field
[0003] The field of the presently claimed embodiments of the invention relates to medical devices, and more particularly, to the delivery and anchoring of medical devices within tissue cavities and / or luminal tissue spaces using specialized delivery systems and endoscopes. Background Art
[0004] There are delivery and anchoring devices for medical devices. However, delivery and anchoring of medical devices within a tissue cavity and / or luminal tissue space can be challenging. There is a need to improve existing anchoring of medical devices, particularly within a tissue cavity and / or luminal tissue space. Summary of the invention
[0005] According to some embodiments of the present invention, an anchoring system includes: a sleeve having an inner surface defining a lumen; a first expandable sealing mechanism disposed along a proximal end of the sleeve; and a second expandable sealing mechanism disposed along the proximal end of the sleeve. The anchoring system also includes an open-cell foam disposed on an outer surface of the sleeve. Expansion of the first and second expandable sealing mechanisms and application of negative pressure to the anchoring system results in a seal formed between the first and second expandable sealing mechanisms, the outer surface of the sleeve, and the inner surface of the tissue cavity.
[0006] According to one embodiment, the anchoring system further comprises a sleeve body. According to one embodiment, the first inflatable sealing mechanism is disposed at the proximal end of the sleeve body, and the second inflatable sealing mechanism is disposed at the distal end of the sleeve body. According to some embodiments, the sleeve body and the sleeve are formed of the same polymer extrusion. According to other embodiments, the sleeve body is a separate tubular structure coupled to the tubular structure of the sleeve. According to some embodiments, the sleeve body of the anchoring system has a thicker wall thickness than the sleeve of the system. According to some embodiments, the sleeve body of the anchoring system has a higher hardness than the sleeve of the system. According to some embodiments, the sleeve body of the anchoring system is configured such that when the inflatable sealing mechanism is inflated within the tissue cavity and negative pressure is applied to the anchoring system, the cavity does not collapse closed. According to some embodiments, the sleeve body of the anchoring system is configured such that when the sealing element is inflated within the tissue and negative pressure is applied, the inflatable sealing mechanism remains in a nearly vertical orientation relative to the sleeve body.
[0007] According to some embodiments, the distal end of the sleeve body is connected to the proximal end of the sleeve. According to another embodiment, the sleeve body is coextensive with the sleeve. According to some embodiments, the sleeve body is disposed on the proximal end of the sleeve.
[0008] According to one embodiment, the sleeve includes a plurality of fluid lumens. According to some embodiments, the plurality of fluid lumens include one or more of: (i) a distal fluid lumen to provide fluid to the first expandable sealing mechanism, (ii) a proximal fluid lumen to provide fluid to the second expandable sealing mechanism, (iii) an irrigation lumen, (iv) a contrast dye lumen, and (v) a negative pressure lumen.
[0009] According to some embodiments of the present invention, the application of negative pressure generates a friction force that resists displacement of the sleeve and / or the sleeve body. According to some embodiments of the present invention, the application of negative pressure causes the open-cell foam disposed on the outer surface of the sleeve to contact the inner surface of the tissue cavity, thereby generating a friction force that resists displacement of the sleeve.
[0010] According to some embodiments of the present invention, the first and second inflatable sealing mechanisms are inflated by providing an incompressible fluid (e.g., saline, mineral oil and / or a dye-based (e.g., iodine-based) contrast solution) to inflate or expand the first and second inflatable sealing mechanisms. According to some embodiments of the present invention, the first and second inflatable sealing mechanisms are inflated by a radiopaque liquid. According to some embodiments of the present invention, the first and second inflatable sealing mechanisms are inflated by filling with an incompressible liquid. According to some embodiments, the inflatable sealing mechanism is inflated by filling with air. According to one embodiment, once expanded, the first and second inflatable sealing mechanisms form a substantially gas- and fluid-impermeable seal with the inner surface of the tissue cavity. According to some embodiments of the present invention, the first and second inflatable sealing elements are collapsible.
[0011] According to some embodiments of the present invention, the sleeve protects the inner surface of the tissue cavity from the influence of the feces flow on the far side of the sleeve body. According to some embodiments, the lumen has a diameter between about 1cm and about 6cm. According to some embodiments, the outer surface of the sleeve and / or the sleeve body has a diameter between about 1.1cm and about 6.1cm. According to some embodiments, the sleeve and / or the sleeve body comprises a flexible material with a Shore A hardness between about 20A and about 70A. According to some embodiments, the sleeve and / or the sleeve body has a length between about 3cm and about 25cm. According to some embodiments, the sleeve and / or the sleeve body has a tubular wall thickness between about 0.1mm and about 8mm. According to some embodiments, the sleeve and / or the sleeve body has a tubular wall thickness between about 0.2mm and about 5mm.
[0012] According to some embodiments of the present invention, the open-cell foam comprises a material having an average pore size between about 50 microns and about 1000 microns. According to some embodiments, the open-cell foam comprises a material having an average pore size between about 300 microns and about 600 microns. According to some embodiments, the open-cell foam comprises a material having an average pore size between about 200 microns and about 400 microns. According to some embodiments, the open-cell foam comprises a material having an average pore size between about 100 microns and about 300 microns. According to some embodiments, the open-cell foam can be compressed by peristaltic contractions of the patient's intestine. According to some embodiments, the open-cell foam can be compressed by negative pressure between the sealing element, the sleeve and the tissue cavity. According to some embodiments, the open-cell foam comprises polyvinyl alcohol, polyurethane foam or other synthetic polymers. According to some embodiments, the open-cell foam has a tensile strength of at least 50 kPa. According to some embodiments, the open-cell foam has a thickness between 2 mm and 150 mm. According to some embodiments, the open-cell foam comprises a single tubular foam piece. According to some embodiments, the open-cell foam comprises a plurality of foam pieces. According to some embodiments, the open cell foam is bonded to the sleeve and / or the sleeve body. According to some embodiments, the open cell foam has a higher coefficient of friction than the sleeve and / or the sleeve body.
[0013] According to some embodiments, the first and second inflatable sealing mechanisms each comprise an inflatable or expandable elastomeric balloon. According to some embodiments, the first and second inflatable sealing mechanisms each comprise a plurality of inflatable elastomeric balloons. According to some embodiments, the first inflatable sealing mechanism comprises a single inflatable or expandable elastomeric balloon and the second inflatable sealing mechanism comprises several or more inflatable elastomeric balloons. According to one embodiment, the first and second inflatable sealing mechanisms have an annular diameter that is greater than an annular diameter of the open-cell foam dispersed around the sleeve and / or the sleeve body.
[0014] According to some embodiments of the invention, the sleeve has a column strength of about 3.0 lbs to 6.0 lbs. According to some embodiments of the invention, the sleeve has a column strength of about 3.0 lbs to 6.0 lbs. According to some embodiments, the combined sleeve body and sleeve have a column strength of 3.0 lbs to 6.0 lbs.
[0015] According to some embodiments of the present invention, the anchoring system further comprises a collection bag disposed at the distal end of the sleeve and configured to manage intestinal contents delivered from the anchoring system. According to one embodiment, the anchoring system further comprises a retaining dressing to attach the anchoring system to the skin. According to one embodiment, the anchoring system further comprises an extension tube connected to the distal end of the sleeve, the extension tube configured to extend the anchoring system outside the patient's body. According to some embodiments, the extension tube is between 1 ft and 6 ft. In some embodiments, the extension tube is connected to an outflow bag.
[0016] According to some embodiments of the present invention, the anchoring system further comprises a scope adapter configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope. According to one embodiment, the scope adapter comprises a body, a compression nut, a compression sleeve, and a compression washer. According to one embodiment, the body comprises a plurality of threads configured to engage with a plurality of grooves disposed along an inner surface of the compression nut. According to some embodiments, the anchoring system further comprises a connector latch point configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope via the scope adapter. According to some embodiments of the present invention, the scope adapter holds the extracorporeal end portion of the anchoring system in a fixed position over the length of the scope. According to some embodiments, the scope adapter is configured to allow the extracorporeal end portion of the anchoring system to be fixed to different positions along the length of the scope. In some embodiments, the scope adapter is configured to hold the extracorporeal end portion of the anchoring system with a longitudinal pulling or pushing force of at least 3 lbs. In some embodiments, the scope adapter is configured to be quickly released from the extracorporeal end portion of the anchoring system to allow withdrawal of the scope from within the body and leave the anchoring system in place.
[0017] According to some embodiments of the present invention, the anchoring system further comprises a negative pressure source, wherein negative pressure is applied to the anchoring system by the negative pressure source to maintain one of a constant negative pressure or a variable negative pressure at a level between -50 mmHg and -200 mmHg. According to one embodiment, the anchoring system comprises a negative pressure lumen, wherein the negative pressure lumen is configured to provide negative pressure to the sleeve and / or the sleeve body. According to some embodiments of the present invention, the anchoring system further comprises a flushing lumen connected to the outer surface fluid of the sleeve and / or the sleeve body. According to some embodiments of the present invention, the anchoring system further comprises a flushing system connected to the fluid of the sleeve and / or the sleeve body, wherein the flushing system introduces fluid into the sleeve and / or the sleeve body for flushing. In some embodiments, the flushing tube connected to the outer surface fluid of the sleeve is the same tube as the pressure tube.
[0018] According to some embodiments of the present invention, the sleeve has a length that allows it to extend outside of the tissue cavity. According to some embodiments, the lumen and the first and second expandable sealing mechanisms can be compressed by normal peristaltic forces of the patient's intestine. According to some embodiments, the diameter of the first expandable sealing mechanism and the second expandable sealing mechanism is less than or equal to the diameter of the tissue cavity in which the sleeve will be anchored. According to some embodiments, the anchoring system is configured so that traction on the sleeve can be used to remove the anchoring system from the body cavity. According to some embodiments, the sleeve has a wall thickness between about 50 microns and about 5 mm. According to some embodiments, the sleeve has a length between about 8 inches and about 72 inches. According to some embodiments, the sleeve has a length between about 3 cm and about 25 cm. According to some embodiments, the sleeve has markings along its length, which indicate the length of the sleeve within the tissue cavity after placement. According to some embodiments, the sleeve body and / or the sleeve are composed of one or more of silicone, polyurethane, thermoplastic elastomer, rubber or other polymers. According to one embodiment, the sleeve and the sleeve body are composed of a continuous tubular extrusion.
[0019] According to some embodiments of the invention, the pressure tube is connected to the sleeve along the length of the sleeve. According to some embodiments, the pressure tube is disposed within the wall of the sleeve. According to some embodiments, the pressure tube is integrated into the sleeve and comprises the same material as the sleeve. According to some embodiments, the pressure tube is disposed within an additional lumen along the length of the sleeve.
[0020] According to some embodiments of the present invention, the sleeve body and / or the sleeve are made of one or more of silicone, polyurethane, thermoplastic elastomer, rubber, rubber-like material or other polymers.
[0021] According to some embodiments of the present invention, the anchoring system further comprises a plurality of pressure tubes fluidly connected to the outer surface of the sleeve and / or the sleeve body.
[0022] According to some embodiments of the present invention, the anchoring system further comprises an outflow bag in fluid connection with the sleeve, the outflow bag being configured to receive the contents of the sleeve. According to some embodiments, the outflow bag is detachable. In some embodiments, the outflow bag can be emptied of the contents without being detached from the sleeve.
[0023] According to some embodiments of the present invention, the sleeve has a proximal end that is in sealing fluid communication with and extends distally to the distal end of the sleeve body and the second expandable sealing mechanism, wherein the proximal end of the sleeve that extends distally to the distal end of the sleeve body is configured to cover and protect a damaged area of tissue of the tissue cavity from contents flowing through the lumen of the sleeve and the sleeve body. According to some embodiments of the present invention, the sleeve body is bonded around the sleeve. According to some embodiments, the sleeve body and the sleeve of the anchoring system are a single continuous polymer piece such that the sleeve body shares the same lumen with the sleeve.
[0024] According to some embodiments of the invention, the sleeve and / or sleeve body and the first and second inflatable sealing elements are made from a single injection mold using a single material. According to some embodiments, the sleeve includes a releasable fluid-tight connector between 8 inches and 36 inches from the second inflatable sealing mechanism. According to some embodiments, the sleeve includes a breakaway joint between 8 inches and 36 inches from the second inflatable sealing mechanism. According to some embodiments, the anchoring system is configured to be positioned in a tissue cavity using an endoscope.
[0025] According to some embodiments, the tissue cavity is an intestine, the intestine comprising an anastomosis, and wherein the anchoring system is positioned within the intestine such that the anastomosis is located distally of the second expandable sealing mechanism in the intestine. According to some embodiments, the anchoring system further comprises an irrigation system fluidly connected to the sleeve and / or the sleeve body, wherein the irrigation system introduces fluid into the sleeve and / or the sleeve body for irrigation.
[0026] According to some embodiments, there is an irrigation tube extending from outside the body to the intestine, the irrigation tube being in the intestine proximal to the first expandable sealing mechanism. In some embodiments, the irrigation tube is used to dilute feces proximal to the intestinal end that impacts the anchoring system.
[0027] According to some embodiments, there is an additional irrigation tube extending from outside the body to the intestine, the additional irrigation tube being in the intestine distal to the second expandable sealing mechanism. In some embodiments, the additional irrigation tube is used to irrigate the anastomosis. In some embodiments, the additional irrigation tube is used to spray contrast agent to check for anastomotic leaks using radiographic studies.
[0028] According to some embodiments of the present invention, a delivery system includes: an outer protective sheath enclosing an anchoring system according to an embodiment of the present invention; a handle; a guide shaft; and a sheath puller. The anchoring system is configured to be pushed into a suitable position by advancing the guide shaft into the intestine of a patient. According to some embodiments, the outer protective sheath of the delivery system is withdrawn through the center of the guide shaft to expose an expandable seal and an air-conducting rough surface material (or open-cell foam) disposed on the outer surface of the sleeve body. In some embodiments, the outer protective sheath extends only to cover the sleeve body of the anchoring system containing the sealing element and the foam.
[0029] According to some embodiments, a delivery system is provided, comprising: a handle; a guide shaft connected to the handle; an outer protective sheath; and a sheath puller attached to the outer protective sheath. According to one embodiment, the outer protective sheath is disposed within a central lumen of the guide shaft and is configured to extend from the central lumen to cover and protect the proximal end of the anchoring system having the at least one expandable sealing mechanism. According to one embodiment, the delivery system is used with an anchoring system according to an embodiment of the present invention, the anchoring system having a sleeve having a column strength high enough to prevent the system from collapsing during insertion through the delivery system.
[0030] According to some embodiments of the present invention, the air-conducting rough surface material is disposed on the outer surface of the sleeve body or proximally in the main body portion of the sleeve. According to some embodiments, the air-conducting rough surface material is a stacked mesh matrix, a honeycomb grid of interconnected channels, a gauze, a fabric, or a three-dimensional woven material, which can be oriented around the sleeve, for example, in a radial manner.
[0031] According to some embodiments of the present invention, a method for anchoring a sleeve in a tissue cavity, the sleeve having an outer surface, the outer surface including a foam for contacting an inner wall of the tissue cavity, and an expandable sealing mechanism for isolating a portion of the tissue cavity adjacent to the sleeve from the remainder of the tissue cavity, the method comprising: inserting the sleeve into the tissue cavity. The method also includes inflating or expanding the expandable sealing mechanism to create a seal between the expandable mechanism and the inner surface of the tissue cavity, and applying negative pressure to an area between the outer surface of the sleeve and the inner surface of the isolated portion of the tissue cavity to create friction between the foam of the sleeve and the inner surface of the tissue cavity. According to one embodiment, the sleeve also includes a sleeve body.
[0032] According to some embodiments of the invention, the step of inflating or expanding the inflatable sealing mechanism is performed by injecting an incompressible liquid into the inflatable sealing mechanism. According to some embodiments of the invention, the step of inflating or expanding the inflatable sealing mechanism is performed by injecting an inflation medium (e.g., saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution) into the inflatable sealing mechanism. According to some embodiments, the step of inflating or expanding the inflatable sealing mechanism is performed by injecting a radiopaque contrast agent into the inflatable sealing mechanism.
[0033] According to some embodiments of the invention, the step of inserting the sleeve into the tissue cavity is performed using a delivery system comprising a handle and a guide shaft. According to one embodiment, the method further comprises the step of withdrawing the handle and the guide shaft of the delivery system from the sleeve.
[0034] According to some embodiments of the present invention, the method further comprises removing the sleeve from the tissue cavity by: (i) releasing the negative pressure; (ii) collapsing the expandable sealing mechanism; and (iii) injecting a certain amount of saline through the irrigation tube to destroy the seal.
[0035] According to some embodiments of the present invention, there is provided an anchoring device utilizing two redundant methods of anchoring within the intestine, wherein the first method is utilizing a negative pressure based friction anchor as described herein, and the second method is securing an external portion of the device to the skin, wherein the sleeve has a column strength such that even if there is a failure in the first method of anchoring, the column strength is high enough to hold the anchor portion of the device in place; and such that if there is a failure in the second method, the first method of securing is sufficient to hold the anchor portion of the device in place. According to embodiments of the present invention, there is provided a method of inserting an anchoring system according to embodiments of the present invention, the method utilizing an endoscope connected to the anchoring system. According to some embodiments, the anchoring system is inserted using direct visualization via the endoscope.
[0036] According to some embodiments of the present invention, an anchoring system includes: a sleeve having an inner surface defining a lumen; a first inflatable sealing mechanism disposed along a proximal end of the sleeve; and a second inflatable sealing mechanism disposed along the proximal end of the sleeve. The anchoring system also includes an air-conducting rough surface material disposed on an outer surface of the sleeve. Inflation of the first and second inflatable sealing mechanisms and application of negative pressure to the anchoring system results in a seal formed between the first and second inflatable sealing mechanisms, the outer surface of the sleeve, and the inner surface of the tissue cavity.
[0037] According to some embodiments, the system further comprises a sleeve body, the first inflatable sealing mechanism is disposed at a proximal end of the sleeve body, and the second inflatable sealing mechanism is disposed at a distal end of the sleeve body. According to some embodiments of the present invention, the air-conducting rough surface material is at least one of a stacked mesh matrix, a honeycomb grid of interconnected channels, a gauze, a fabric, or a three-dimensional woven material.
[0038] According to some embodiments of the present invention, an anchoring device configured to be anchored in a patient's intestine is provided, the anchoring device comprising: a sleeve configured to be positioned in the patient's intestine; an external portion configured to extend outside the patient's intestine; and two redundant methods of anchoring the device in the intestine, wherein a first method of anchoring the device utilizes a negative pressure-based system that applies negative pressure to the device to generate friction that resists displacement of the sleeve of the device from the intestine, wherein a second method of anchoring the device secures the external portion of the device to the patient's skin, wherein at least one of the following features is present: (i) the column strength of the sleeve is high enough to keep the device in place even if there is a failure in the first method of anchoring, or (ii) the first method of anchoring is sufficient to keep the device in place even if there is a failure in the second method of anchoring.
[0039] According to one embodiment, the anchoring device also includes a redundant third method of anchoring the device, wherein the third method of anchoring utilizes first and second inflatable sealing mechanisms, wherein expansion of the first and second inflatable sealing mechanisms causes a seal to be formed between the first and second inflatable sealing mechanisms and the inner surface of the tissue cavity, wherein the third method of anchoring is sufficient to maintain the device in place even if there is a failure in the first method of anchoring and / or the second method of anchoring. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Further objects and advantages will become apparent from consideration of the description, drawings and examples.
[0041] Figure 1A is a diagrammatic representation of an anchoring system according to some embodiments of the present invention.
[0042] Figure 1B is an illustration of an end view of an expandable sealing mechanism of an anchoring system according to an embodiment of the present invention.
[0043] Figure 1C is a schematic diagram of an end view of an expandable sealing mechanism of an anchoring system according to an embodiment of the present invention.
[0044] Figure 1D is a schematic diagram of an end view of an expandable sealing mechanism of an anchoring system according to an embodiment of the present invention.
[0045] Figure 2A is a schematic diagram of an anchoring system in a collapsed position according to some embodiments of the present invention.
[0046] Figure 2B According to an embodiment of the present invention Figure 2A Schematic diagram of an end view of the anchoring system shown.
[0047] Figure 2C is a schematic diagram of an end view of a sleeve lumen of an anchoring system according to some embodiments of the present invention.
[0048] Figure 3 is a schematic diagram of an anchoring system according to some embodiments of the present invention.
[0049] Figure 4A is a schematic diagram of an anchoring system in a collapsed position according to an embodiment of the present invention.
[0050] Figure 4B is a schematic diagram of an anchoring system in an expanded position according to an embodiment of the present invention.
[0051] Figure 5 is a schematic diagram of an exploded view of each component of an anchoring system according to some embodiments of the present invention.
[0052] Fig. 6A A method for inserting an anchoring system into a tissue cavity using a flexible member and a semi-rigid tube pusher is shown.
[0053] Figure 6B The anchoring system is shown detached from the delivery system (flexible member and pushing member removed) and in a desired position.
[0054] Figure 6C The anchoring system is shown with the intestinal wall collapsing around the sealing member and the anchoring sleeve body upon application of negative pressure via the pressure tube.
[0055] Fig. 7A is a schematic diagram of a distal fluid path of an anchoring system in an expanded position according to an embodiment of the present invention.
[0056] Figure 7B is a schematic diagram of a proximal fluid path of an anchoring system in an expanded position according to an embodiment of the present invention.
[0057] Figure 8 is a schematic diagram of a contrast agent lumen of an anchoring system in an expanded position according to an embodiment of the present invention.
[0058] Fig. 9is a schematic diagram of a negative pressure path of an anchoring system in an expanded position according to an embodiment of the present invention.
[0059] Fig. 10A A delivery system for an anchoring system according to some embodiments of the present invention is shown.
[0060] Fig. 10B is a schematic diagram of a delivery system in combination with an anchoring system according to an embodiment of the present invention.
[0061] Fig. 10C According to an embodiment of the present invention, Fig. 10B A cross-sectional view of the delivery system in combination with the anchoring system is shown.
[0062] Fig. 10D According to an embodiment of the present invention, Fig. 10B and 10C An enlarged partial cross-sectional view of the handle of the delivery system in combination with the anchoring system is shown.
[0063] Fig. 10E According to an embodiment of the present invention Fig. 10B and 10C An enlarged partial cross-sectional view of the end of the anchoring system together with the delivery system is shown.
[0064] Fig.10F According to an embodiment of the present invention, Fig. 10E The line AA is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown.
[0065] Figure 10G According to an embodiment of the present invention, Fig. 10E The line BB intercepts Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown.
[0066] Fig. 10H According to an embodiment of the present invention, Fig. 10E The line CC is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown.
[0067] Fig.10I According to an embodiment of the present invention, Fig. 10E The line DD is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown.
[0068] Fig.10J According to an embodiment of the present invention, Fig. 10E The line EE is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown.
[0069] Fig.11A is a schematic diagram of a delivery system for use with an anchoring system according to another embodiment of the present invention.
[0070] Fig. 11B According to an embodiment of the present invention, Fig.11A A cross-sectional view of a delivery system for use with an anchoring system is shown.
[0071] Fig. 11C According to an embodiment of the present invention Fig.11A and 11B An enlarged partial cross-sectional view of an end portion of a delivery system is shown.
[0072] Fig.11D According to an embodiment of the present invention Fig.11A and 11B An enlarged partial cross-sectional view of the handle of the delivery system is shown.
[0073] Fig.12 An extension tube for an anchoring system according to some embodiments of the present invention is shown.
[0074] Fig.13 An embodiment of an anchoring system comprising two anchoring elements to deliver a therapeutic agent to an isolated intestinal segment is shown.
[0075] Fig.14 Shown is a side view of an embodiment of an anchoring system comprising two anchoring elements to deliver a therapeutic agent to an isolated intestinal segment.
[0076] Fig.15A and 15B is a schematic diagram of a scope adapter according to some embodiments of the present invention.
[0077] Fig.16 According to an embodiment of the present invention, Fig.15A The line 16-16 is intercepted Fig.15A and 15A A cross-sectional view of a scope adapter is shown.
[0078] Fig.17 is a schematic diagram of an anchoring system attached to an endoscope via a scope adapter according to some embodiments of the present invention.
[0079] Fig.18 According to an embodiment of the present invention, Fig.17 The line 18-18 is intercepted Fig.17 A cross-sectional view of a scope adapter is shown.
[0080] Fig.19A is a schematic diagram of a retention dressing for securing an anchoring system to a patient according to some embodiments of the present invention.
[0081] Figures 19B-19H According to an embodiment of the present invention, Fig.19A Schematic diagram of a method of retaining a dressing attached to an anchoring system is shown.
[0082] Fig. 20A is a schematic diagram of a collection bag according to some embodiments of the present invention.
[0083] Fig. 20B According to an embodiment of the present invention, Fig. 20A Schematic diagram of a pair of attachment straps for attaching a collection bag to a patient.
[0084] Fig.21A is a schematic diagram of a collection bag according to some embodiments of the present invention.
[0085] Fig. 21B According to an embodiment of the present invention Fig.21A Side view of the collection bag. DETAILED DESCRIPTION
[0086] Together with the benefits and improvements that have been disclosed, other objects and advantages of the present disclosure will become apparent from the following description in conjunction with the accompanying drawings. Specific embodiments of the present disclosure are disclosed herein; however, it should be understood that the disclosed embodiments are merely illustrations of the present disclosure that can be implemented in various forms. In addition, each example given with respect to the various embodiments of the present disclosure is intended to be illustrative rather than restrictive.
[0087] Throughout the specification and claims, unless the context clearly dictates otherwise, the following terms take the meanings explicitly associated herein. The phrases "in one embodiment," "in an embodiment," and "in some embodiments" as used herein do not necessarily refer to the same embodiment, although they may be. In addition, the phrases "in another embodiment" and "in some other embodiments" as used herein do not necessarily refer to different embodiments, although they may be. All embodiments of the present disclosure are intended to be combinable without departing from the scope or spirit of the present disclosure.
[0088] As used herein, the term "based on" is not exclusive and allows for being based on additional factors that are not described unless the context clearly dictates otherwise. In addition, throughout the specification, the meanings of "a", "an", and "the" include plural references. The meaning of "in..." includes "in..." and "on...".
[0089] As used herein, terms such as "comprising," "including," and "having" do not limit the scope of a particular claim to the materials or steps recited by the claim.
[0090] As used herein, terms such as "consisting of and "composed of" limit the scope of a particular claim to the materials or steps recited in the claim.
[0091] All prior patents, publications, and test methods cited herein are incorporated by reference in their entirety.
[0092] After surgical intestinal resection and anastomosis or when the intestinal wall is damaged (e.g., tissue injury), the need to temporarily protect the intestinal lumen and / or intestinal segments from the impact of intestinal fecal flow is a common problem in modern medical treatment. Examples include, for example, protecting newly formed surgical anastomoses, anatomical leaks, inflamed or irritated intestines, partial thickness damage to the intestinal wall, and full thickness intestinal perforations. The traditional method of temporarily protecting the intestine from the impact of fecal flow is to create an external diversion of the intestine by creating an ostomy or stoma. An ostomy is a purposeful anastomosis between a gastrointestinal (GI) tract segment and the skin of the anterior abdominal wall. Basically, the surgeon diverts a segment of the intestine proximal to the area to be protected to the skin, allowing the fecal flow to bypass the vulnerable intestinal segment. An ostomy can actually be created anywhere along the GI tract. For the diversion of fecal flow, the most common ostomies involve the distal small intestine (e.g., ileostomy) and the large intestine (e.g., colostomy). Ostomies are performed in approximately 300,000 patients in the U.S. and more than 2 million patients worldwide each year, but this surgery is complicated due to high morbidity, mortality, and severe impact on the patient's quality of life. Complications such as parastomal hernia, infection / sepsis, skin irritation and erosion, electrolyte depletion, dehydration, and prolapse are common. Up to 50% of patients undergoing ostomy surgery will have some type of ostomy-related complications, many of which require re-hospitalization or additional operations. Although many ostomies are intended to be temporary, up to 1 / 3 of temporary ostomies have never been reversed due to, for example, patient fear of undergoing further surgery or risk factors associated with complications from the original surgery. In addition, reversal surgery itself is associated with a high complication rate (17%) and a significant mortality rate (1.2%-7%). Therefore, improved methods and devices are needed to provide a less prone alternative to fecal diversion for colon protection.
[0093] One of the main indications for temporary ostomy is to protect the intestinal anastomosis after bowel resection surgery. Protective ostomy or stoma is performed to protect the newly formed anastomosis from fecal flow and prevent the development of severe sepsis in the event of anastomotic leakage. Anastomotic leakage is defined as a defect in the intestinal wall at the site of the anastomosis, resulting in communication between the intraluminal and extraluminal compartments. The overall incidence of colorectal anastomotic leakage varies widely in the literature, ranging from 1% to 24%. Leakage can cause serious complications such as anastomotic loss, sepsis, and death. Even in those cases where the anastomosis is salvaged, poor compliance of the neorectum can lead to poor functional outcomes. In many large studies, anastomotic leakage has been shown to be associated with pelvic sepsis at a rate of 50%. By protecting the anastomosis from fecal flow, anastomotic leakage can be prevented, or perhaps more importantly, their complications and death from severe sepsis can be mitigated. This is why colon surgeons perform temporary ostomies after bowel resection, even though the vast majority of patients will likely heal uneventfully. Even after anastomotic leaks occur, protection from the flow of feces makes the anastomotic leak less severe and aids in the healing of the leak. There are several risk factors for the development of anastomotic leaks. The most important risk factor is the level of the anastomosis, with the rate of leakage increasing as the distance from the anastomosis to the anus decreases. In addition to meticulous technique in creating the anastomosis, the main strategy for preventing and treating anastomotic leaks during complex or high-risk situations involving bowel resections is to divert the flow of feces with a protective ostomy. This is accomplished by diverting the flow of intestinal contents using an ostomy created in the intestine proximal to the anastomotic leak. Proximal in the intestine is defined as more superior in the GI tract toward the mouth, and distal in the intestine is defined as more inferior in the GI tract toward the anus. The ostomy can be an end-ostomy, such as an end-colostomy or an end-ileostomy, or can be a diverting loop ileostomy that does not completely disrupt intestinal continuity.
[0094] Temporary diverting ostomy and its closure have their own set of complications and morbidities, including dehydration due to high output, difficult stoma care, stenosis of the closure site, wound infection, and incisional hernia. The complication rate of ostomy is between 5% and 100%. Complications can be divided into minor complications that do not require surgical intervention and major complications that do. Major complications include stenosis, small bowel obstruction, retraction, necrosis, prolapse, stricture, fistula, and parastomal hernia. In some cases, such as partial small bowel obstruction, patients can be managed conservatively first and surgical intervention can be avoided. For major complications such as stoma necrosis extending more than a few millimeters, surgical intervention is mandatory. Minor complications include dermatitis, electrolyte imbalance, and dehydration from high ostomy output, although the last case often requires early closure of the ostomy. For major complications, the additional costs and morbidity associated with additional operations or hospitalizations may be significant. Even for minor complications, treating complications and providing ostomy education are burdensome for healthcare providers and patients. Some complications such as hernia, prolapse and stenosis may become chronic and often require multiple corrective operations and associated costs. Ostomy also significantly reduces the patient's quality of life. Feces output from the ostomy is collected in an ostomy bag attached to the patient's abdomen. These bags need to be emptied and replaced regularly to properly care for the ostomy and prevent the inadvertent discharge of fecal material. Ostomy appliances may fail and cause leakage. The burden of living under an ostomy may negatively affect the patient's social life and limit physical activity.
[0095] In addition, the reversal of ostomy is a surgical procedure with potential complications because often the abdominal compartment has dense adhesions, which makes it technically challenging and potentially morbid to reestablish normal intestine. The intestine repaired after ostomy removal may also form leaks at the repair site or anastomotic site in the case of loop ileostomy or in the case of end ostomy reattachment. Due to the possibility of intestinal damage and the development of leaks from ostomy reversal surgery, the procedure is also associated with significant mortality. In addition to the costs associated with bringing the patient to the operating room, the patient usually needs to be hospitalized for 2-4 days after surgery until intestinal function is restored. In addition, the reversal of ostomy may be too risky or impossible in some patients, requiring the patient to use ostomy to survive the rest of his life.
[0096] In addition to anastomotic protection, there are other potential indications for temporary fecal diversion. These include: 1) anastomotic leaks after treatment has occurred, 2) diverticulitis, 3) inflammatory bowel disease such as Crohn's or ulcerative colitis, 4) intestinal perforation, and 5) other less common conditions of intestinal injury where fecal diversion may be useful, such as in cases of ischemic bowel disease, intestinal contusion injuries from trauma, or non-healing perineal / perianal wounds. When leaks or intestinal perforations occur, such as in the cases of anastomotic leaks and diverticulitis as examples, treatment with fecal diversion may reduce the severity and extent of the condition. Thus, when ongoing fecal flow contamination of the affected site is alleviated, these patients may heal their leaks / perforations more quickly and without developing more serious complications. Inflammatory conditions of the bowel wall such as Crohn's disease or ulcerative colitis can make the intestinal lining vulnerable to damage from fecal flow. Continued fecal flow can further pro-inflammatory and contaminate the intestinal wall and lead to worsening of the patient's overall illness, infection / sepsis, or even perforation of the intestinal wall. Protection from the effects of fecal flow allows the inflamed portion of the intestine to heal, and potentially, fecal diversion can reduce recovery time, hospital stay, and limit serious complications, such as, for example, perforation or fistula formation. Patients with these conditions may not be good candidates for surgery due to their accompanying conditions or sepsis; therefore, major surgery to create an ostomy in these cases may be morbid. Therefore, improved methods and devices are needed to provide a less morbid alternative for temporary fecal diversion.
[0097] Recently, attempts have been made to use an intestinal protective sleeve / sheath as an alternative to temporary ostomy formation for endoluminal diversion. Instead of utilizing an ostomy / stoma to divert stool to the outside of the body, stool is diverted through the lumen inside the protective sleeve / sheath, thereby effectively protecting the intestinal wall from fecal contamination. However, firmly and securely anchoring the sleeve / sheath within the intestinal lumen has proven to be historically challenging. Previous attempts at intestinal anchoring have either resulted in potentially catastrophic complications (erosion or ischemic damage to the intestinal wall, increased anastomotic leak rates), or in unreliable anchoring and protection (early extrusion, device migration, incomplete fecal bypass). Historically, these sleeves have been inserted blindly with or without direct visualization during laparoscopy or laparotomy. However, avoiding inadvertently causing intestinal damage during blind insertion of the protective sleeve / sheath can be risky because intestinal wall damage or other intestinal pathology (e.g., inflammation) can make the intestinal wall more susceptible to iatrogenic injury. However, there are many clinical scenarios that require placement of an anchor and attached sleeve without associated surgical laparoscopy or laparotomy. In these cases, performing a laparoscopy or laparotomy to assist in placement of the device would expose the patient to additional risks and potential complications from surgery, which could limit indications for use to only the most severe cases where the benefits of colon protection outweigh the potential morbidity of abdominal surgery. The ability to safely anchor a protective sleeve / sheath without performing a laparoscopy or laparotomy would increase indications for use of the protective device and minimize the morbidity of using the device. Therefore, there is a need for a device to protect intestinal segments that can be safely placed by a completely endoluminal approach without the need for laparoscopy or laparotomy. There are many clinical examples where this technology would be beneficial. For example, conditions requiring temporary colon protection can include, for example, high-risk colonoscopies, inflammatory bowel disease, or diverticulitis.
[0098] Disclosed herein are systems and methods for anchoring a protective sleeve within the intestine proximal to an intestinal region that requires protection from fecal flow, such as an intestinal anastomosis or an intestinal injury region. The systems and methods may make a temporary fecal diversion ostomy unnecessary in most patients because it provides internal fecal diversion and achieves the same overall goals as a temporary ostomy by protecting a distal segment of the intestine from fecal flow. In addition, additional configurations of such a system are disclosed that enable drug delivery to the intestinal lumen.
[0099] According to one embodiment, an anchoring system or intraluminal colonic diversion (ICD) system is provided, which is a medical device designed to temporarily protect a segment of the colon from the flow of feces. The system or product is intended to improve patient care by reducing the need for temporary stomas following intestinal wall injury. The ICD system is a two-part system that includes (i) a sterile, single-patient-use ICD device and (ii) a sterile, single-patient-use ICD delivery system. The ICD device and the ICD delivery system are assembled ready for use in a bag, such as, for example, a Tyvek-PET / LDPE bag, and the sealed bag is packaged in a single particleboard box as a complete ICD system.
[0100] According to some embodiments, the system (i.e., ICD system) includes an anchoring mechanism that allows non-traumatic and reversible anchoring of a sleeve within the GI tract that diverts fecal contents away from the anastomotic site or damaged intestinal area. The device is designed to remain in place for a period of days to weeks (including, for example, 10-14 days, up to 21 days, and / or at least four weeks) and then be completely removed from the patient after healing occurs or diversion is no longer required. Although the devices and methods described herein are in the context of firmly anchoring a sleeve within the GI tract for therapeutic benefits such as diverting intestinal contents, the devices and methods for anchoring may also have applications in other body regions where secure anchoring within a tissue cavity is desired. It is important to emphasize that this is a device designed to be substantially and firmly anchored in place within the intestine and prevent significant device migration until the device is actively separated and removed by a clinician. This is in contrast to other non-surgically attached sheaths or sheath-based protective devices, which cannot be firmly anchored and slowly squeeze out of the intestine over time because they cannot maintain the same level of anchoring strength required to resist the intestinal expulsion forces. The unique design of the device disclosed herein allows it to be anchored in place in the intestine without displacement, without damaging the intestinal wall, without the need for surgical fixation, such as suturing, stapling, or a retaining ring outside the intestine, and without the need for a permanent implant. Each of these features will be described in more detail below.
[0101] According to one embodiment, the ICD device includes a specialized negative pressure anchor and an associated protective sleeve designed to reliably, reversibly and safely protect the distal intestine (i.e., the intestine downstream of the anchor in the gastrointestinal (GI) tract) from the intestinal flow of feces. The specialized negative pressure anchor uses a unique foam interface (or air-conducting rough surface material) to produce a non-traumatic but strong bond to the intestinal wall, which keeps the ICD device in place and prevents migration. According to one embodiment, the anchor portion of the ICD device has an expandable sealing mechanism in the form of, for example, two soft inflatable elastomeric balloons, which provides a non-traumatic sealing surface to facilitate negative pressure anchoring and provides a fluid-tight / gas-tight seal to the anchor portion in the intestine that resists fecal contamination. These seals are also collapsible to allow the anchoring system to be withdrawn without straining the intestinal wall. Negative pressure is applied to the sealing area between the expandable sealing mechanism or the expanded sealing mechanism (e.g., the inflated balloon) and the intestinal lumen to activate anchoring. A biocompatible elastomeric open-cell foam material is spaced between an expandable sealing mechanism (e.g., a balloon) to provide a large contact surface and a means for evenly distributing negative pressure around the outer surface of the anchor sleeve and / or anchor sleeve body and the inner intestinal wall. The interface also creates a unique friction bond to the intestinal wall that is stronger than previously achieved without the use of more invasive fixation techniques. The ICD device is designed to be placed in the operating / operating room and can be removed at the patient's bedside or clinically. The ICD device does not require surgical fixation, such as, for example, stapling, extraluminal restraining rings, or expandable silk stents, which can damage the delicate intestinal wall. The ICD device can remain in place, typically for a period of 10 to 14 days, although it can be left in place for up to 21 days or longer if necessary to provide extended protection for surgical intestinal anastomoses or damaged intestinal segments, such as, for example, anastomotic leaks and / or inflamed bowel.
[0102] According to some embodiments, the device includes a negative pressure-based anchor that prevents the sleeve and / or sleeve body from becoming displaced from the inner surface of the intestine. According to some embodiments, the sleeve includes a sleeve body and / or is connected to the sleeve body, and the combination acts as a protective barrier between the GI tract and the GI contents flowing through the sleeve and the sleeve body. In some embodiments, the sleeve body is added to the proximal end of the sleeve. In some embodiments, the sleeve and the sleeve body are manufactured as a continuous tubular structure. In some embodiments, the sleeve and the sleeve body are separate tubular components that are combined together. According to one embodiment, the sleeve body is a reinforcing member designed to support the proximal end of the sleeve and / or the device, and more specifically, the anchor element. The sleeve body is a critical component to the function of the device and (1) provides added support to allow for expansion of the expandable sealing member (e.g., balloon) without collapsing the sleeve lumen, (2) helps maintain the expandable sealing member (e.g., balloon) at an angle perpendicular to the sleeve and provides support to prevent them from twisting sideways when expanded, and (3) maintains an open and non-closed central lumen of the sleeve at the proximal end by providing the necessary added support / strength to the sleeve. This allows for a thinner, softer, and more flexible sleeve catheter along the length of the device.
[0103] According to some embodiments, the device includes a pneumatic system for applying negative pressure to the anchor system. In some embodiments, the device includes an external outflow bag to collect GI contents that flow through the sleeve. However, the external outflow bag is not required for the device to function. In some embodiments, the device has a sleeve that opens just outside the anal sphincter and feces can pass through this opening. In this embodiment, the anal sphincter contracts around the sleeve and provides some continence and no collection bag is required.
[0104] According to some embodiments, the anchoring portion of the device is positioned in the GI tract on the proximal side of the anastomosis, or proximal to the damaged intestinal area. The anchoring portion of the device is defined as the portion containing the expandable sealing element and the foam interface. The proximal side is the side that is upstream in terms of the flow of GI contents through the GI tract. This is in contrast to an anastomotic or wound treatment system that is configured to be applied directly to the anastomotic or wound site. The device is configured to anchor in a healthy, undamaged intestine. Constant and / or variable negative pressure is maintained via a pneumatic interface connected to the anchoring system and dispersed through an open-cell reticulated foam interface (or air-conducting rough surface material). The expandable sealing element at the end of the sleeve and / or the end of the sleeve body creates a negative pressure space between the outer surface of the sleeve and / or the sleeve body containing the foam interface and the intestinal wall. When negative pressure is applied, the pressure gradient acts through the foam to create adhesion and friction between the GI tract and the anchoring system. Compared to the sleeve anchoring system of other non-surgical fixation described above, these adhesions and frictional forces generated by the negative pressure-sponge interface enable the anchoring system to maintain a relatively much more fixed position in the intestine. Compared with other forms of fixation (e.g., stapling, suturing, expandable stents or external fixation rings), this fixation is also substantially safer for intestinal damage. When the user is ready to remove the device, the normal atmospheric pressure between the anchoring device and the intestine can be reestablished, thereby allowing the device to move through the GI tract with minimal friction. The fixed device and method do not require suturing, stapling, biodegradable implants, external fixation rings or other invasive anchoring techniques, and minimal trauma is produced to the intestine. Therefore, a method and device for firmly fixing a sleeve and / or a sleeve body in the intestinal lumen in the following manner is disclosed herein, which does not substantially damage the intestinal wall and allows fixation to be easily reversed for device removal.
[0105] According to the features of an embodiment of the present invention, a device for anchoring a sleeve and / or a sleeve body in the intestine can be described as having a hollow body, one or more expandable sealing elements at one or both ends of the hollow body, and a porous material on the outer surface of the hollow body, so that when negative pressure is applied to the outer surface of the hollow body and one or more expandable sealing elements are expanded, an adhesive force is formed between the intestinal wall and the hollow body. At least one lumen can deliver negative pressure (e.g., vacuum) to the sealing member, and one or more other lumens can deliver fluid (e.g., saline, mineral oil and / or dye-based (e.g., iodine-based) contrast solution) to inflate the one or more expandable sealing elements. A protective sleeve can be attached to the sealing member, and a collection system can collect the contents that pass through the sealing member.
[0106] According to some embodiments of the present invention, an ICD delivery device is provided, which includes a handle, a guide shaft, an outer protective sheath and a sheath puller, which allows a doctor or surgeon to place an ICD device during surgery, such as a colon resection. The ICD delivery system promotes the placement of the ICD device by maintaining a small anchor profile during insertion and protecting an expandable sealing mechanism (e.g., an expandable elastomeric balloon) from potential damage when the device is inserted into a stapled anastomosis. According to one embodiment, the ICD device is inserted, advanced and positioned transanally together with the ICD delivery system. A water-based lubricant, such as KY-Jelly, is used to facilitate placement. The anchor portion of the ICD device is positioned 5cm to 10cm above an area (such as, for example, an anastomosis after rectal cancer surgery) that needs protection from fecal flow (more proximal in the GI tract). Importantly, the anchor portion of the ICD device is designed to be placed in a healthy intestine, rather than in a damaged intestinal area that needs protection. After positioning the anchor portion, the outer protective sheath is removed by withdrawing the outer protective sheath using the sheath puller. In some embodiments, the withdrawal of the outer protective sheath of the delivery system occurs through the center of the guide shaft. Then, after the outer protective sheath of the delivery system is removed, the device is ready for deployment.
[0107] According to one embodiment of the present invention, the ICD device deployment process is completed by the following actions: (i) inflating the distal and proximal expandable sealing mechanisms respectively by injecting an incompressible fluid (e.g., saline, mineral oil, or dye-based or radiopaque contrast agent) via a syringe connected to the distal and proximal filling ports of the ICD device, (ii) connecting a negative pressure source (e.g., a vacuum source) to the vacuum port to anchor the ICD device and / or activate negative pressure, and (iii) withdrawing the handle and guide shaft of the ICD delivery system from the ICD device. According to another embodiment, the external portion of the ICD device is further anchored to the patient's skin using an adhesive dressing. In some embodiments, an optional extension tube can extend the length of the tube to the outflow bag for bedside gravity use. The ICD device is designed to be easily removed at the bedside or outpatient department without the need for additional invasive procedures. According to one embodiment, removal of the ICD device is accomplished by: (i) disconnecting the negative pressure source (e.g., a vacuum source) and releasing the vacuum; (ii) defusing the distal and proximal inflatable sealing mechanisms (e.g., balloons) by completely removing fluid via syringes connected to the proximal and distal ports of the ICD device, respectively; (iii) injecting a small amount of saline through the vacuum port to disrupt the anchoring seal, and (iv) removing the external dressing and gently pulling the ICD device sleeve until the ICD device is completely removed from the anal verge.
[0108] According to some embodiments, the ICD device includes at least two additional features. According to one embodiment, a flush lumen is provided for instilling saline proximal to the anchor portion of the device (if necessary) to liquefy formed stool and maintain patency of the guide sleeve and / or sleeve body. In some embodiments, the flush lumen is in communication with the proximal intestinal opening of the sleeve and / or sleeve body. According to another embodiment, a contrast agent lumen is provided that can be used to inject a radiopaque dye distal to the anchor portion of the device in the intestine to perform a radiographic leak test.
[0109] According to one embodiment, the ICD system is used with a specialized adhesive dressing, a negative pressure source, and a collection bag. These features can be accessory products to the main system. Additionally, according to one embodiment, the ICD system includes a scope adapter that allows for placement of the ICD device in the intestine by direct visualization using an endoscope or colonoscope for guided insertion.
[0110] According to the features of an embodiment of the present invention, when the ICD device is loaded on a delivery system or an endoscope, sigmoidoscope or colonoscope, the ability of the anchor portion of the ICD device to move forward against external resistance is due to the combined results of (i) the column strength of the size, shape and material type of the outer sleeve body and / or sleeve of the anchor device, and (ii) the internal support provided by the size, shape and material type of the internal support member (e.g., the guide shaft of the delivery system). The internal support member may include the shaft of a colonoscope or other endoscope or the guide shaft of the ICD delivery system. The unique characteristics of the sleeve and / or sleeve body allow the column strength of the anchor system to be supported during advancement into the intestine, which allows the delivery system to function. In addition, the column strength of the sleeve body and / or sleeve allows the external fixation of the ICD device in an appropriate position. According to one embodiment, the relevant yield strength of the column buckling is the compressive yield strength of the selected material. The column strength of the outer sleeve can be calculated and customized by appropriately selecting the material type and material properties. In addition to the column strength of the outer sleeve, the internal support (e.g., the guide shaft of the delivery system) prevents axial and lateral collapse and buckling. Furthermore, the added support allows for the use of softer and / or thinner wall materials while providing the strength necessary to overcome the forward resistance required to insert the device.
[0111] Figure 1AAn illustration of an anchoring system for an ICD device according to some embodiments of the present invention is shown. Anchoring system 100 includes a sleeve body 102 having an inner surface (not shown) defining a lumen (not shown). A proximal end of sleeve body 102 is provided with a first expandable sealing mechanism 108, and a distal end of sleeve body 102 is provided with a second expandable sealing mechanism 110. For this device, proximal is defined as the portion of the device farthest from where fecal matter exits the sleeve body and / or sleeve (as further defined below) (e.g., at the outflow bag), and distal is defined as the portion of the device closer to where fecal matter exits the sleeve body and / or sleeve during normal fecal flow. This orientation convention is used because this is the relationship of flow through the device (from proximal to distal) and matches the orientation of the enteral device. Sleeve 116 is in fluid communication with sleeve body 102 and forms a second lumen (not shown) that is continuous with the first lumen. Open cell foam 120 is disposed on the outer surface of sleeve body 102. The application of negative pressure to the sleeve 116 and / or the sleeve body 102, and the expansion of the first and second expandable sealing mechanisms 108, 110, causes a seal to be formed between the first and second expandable sealing mechanisms 108, 110 and the inner surface of the tissue cavity, and generates a friction force that resists displacement of the sleeve body 102. In some embodiments, the sleeve 116 extends through the sleeve body 102 such that the sleeve 116 is coextensive with the sleeve body 102 (see, e.g., Figure 1C and 1D ). In another embodiment, the sleeve body 102 is not present and the expandable sealing mechanisms 108, 110 and the foam 120 are directly attached to the proximal end of the sleeve 116. In other embodiments, the distal end of the sleeve body 102 is connected to the proximal end of the sleeve 116.
[0112] Figure 1A Also shown are a series of flexible (or fluid) tubes 125, 127, and 129 and their associated connectors or ports 124, 126, 128, respectively. According to one embodiment, one of the flexible tubes 125 provides a fluid or inflation medium (e.g., saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution), such as through its associated connector or port 124, to each of the first and second inflatable sealing mechanisms 108, 110 to inflate the first and second inflatable sealing mechanisms 108, 110, wherein the fluid or inflation medium forms a seal between the first and second inflatable sealing mechanisms 108, 110 and the inner surface of the tissue cavity. Alternatively, the system 100 may include two flexible tubes 125A and 125B (see, e.g., Figure 2B), one for each of the first inflatable sealing mechanism 108 and the second inflatable sealing mechanism 110 to provide a fluid or inflation medium (e.g., saline, mineral oil and / or contrast dye) for inflation. According to one embodiment, a flexible tube or tubing 127 in communication with a connector or port 126 can be used to introduce fluid from a fluid infiltration source (such as, for example, a syringe). The port 126 can be accessed from outside the patient's body via the flexible tube 127. This configuration of the anchoring system 100 allows for the delivery and removal of irrigation, drugs (e.g., antibiotics, anti-inflammatory drugs, or chemotherapeutic agents), and radiological contrast agents between the outer surface of the sleeve 116 and the intestinal wall and between the two inflatable sealing mechanisms 108, 110. For example, according to one embodiment, a flexible tube 127 and port 126 are provided, which can be used to inject contrast dye or radiopaque dye into the intestine distal to the anchor portion of the device to perform a radiographic leak test. According to one embodiment, another flexible tube or tubing 129 is provided, such as, for example, an irrigation tube, which is used to drip a fluid (such as, for example, saline) proximal to the anchor portion of the device (if necessary) to liquefy formed stool and maintain the patency of the sleeve body 102 and / or sleeve 116. For example, according to one embodiment, via the flexible tube or tubing 129 in communication with the connector or port 128, a fluid (such as, for example, saline) can be introduced from a fluid penetration source (such as, for example, a syringe) between the outer surface of the sleeve 116 and the intestinal wall and between the two expandable sealing mechanisms 108, 110. Alternatively, the flexible tube or tubing 129 can be used to introduce a negative pressure source (i.e., a vacuum) to the sleeve 116 and / or the sleeve body 102 to form a seal between the first and second expandable sealing mechanisms 108, 110 and the inner surface of the tissue cavity.
[0113] Figure 1B FIG. 1 is an end view of one of the expandable sealing mechanisms according to an embodiment of the present invention. Figure 1B As shown, the first expandable sealing mechanism 108 includes an outer surface 130, an inner surface 132, and an opening that coincides with the lumen 106 of the sleeve body 102 and the sleeve 116. Figure 1B 108 (and the second expandable sealing mechanism 110) also includes the same configuration. When the first expandable sealing mechanism 108 (and the second expandable sealing mechanism 110) is inflated using a fluid or inflation medium (e.g., saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution) to create a seal between the first expandable sealing mechanism 108 (and the second expandable sealing mechanism 110) and the inner surface of the tissue cavity, the outer surface 130 will be further spaced apart from the inner surface 132.
[0114] Figure 1C FIG. 2 is another end view of one of the expandable sealing mechanisms according to an embodiment of the present invention. Figure 1CAs shown, the first expandable sealing mechanism 108 includes an outer surface 130, an inner surface 132, and an opening that coincides with the lumen 106 of the sleeve body 102 and the sleeve 116. Figure 1C As further shown, the sleeve body 102 extends radially around the inner surface 132 of the first expandable sealing mechanism 108, and the sleeve 116 extends radially around the inner surface of the sleeve body 102. The sleeve 116 also contains various fluid lumens (as discussed in further detail below). Figure 1C Not shown, but the second expandable sealing mechanism 110 also includes the same configuration.
[0115] Figure 1D FIG. 2 is another end view of one of the expandable sealing mechanisms according to an embodiment of the present invention. Figure 1D As shown, the first expandable sealing mechanism 108 includes an outer surface 130, an inner surface 132, and an opening that coincides with the lumen 106 of the sleeve body 102 and the sleeve 116. Figure 1D As further shown, the sleeve body 102 and the sleeve 116 are disposed within the inner surface 132 of the first expandable sealing mechanism 108. The sleeve 116 contains various fluid lumens (as discussed in further detail below). Figure 1D In the end view of FIG. 1 , the foam 120 is shown disposed between the inner surface 132 of the first expandable sealing mechanism 108 and the sleeve body 102. Figure 1D Not shown, but the second expandable sealing mechanism 110 also includes the same configuration.
[0116] Figure 2A The embodiment of the present invention is shown Figure 1A Another illustration of the anchoring system 100. Figure 2A As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110 is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to the sleeve body 102, extending coextensively with the sleeve body, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106 (see, e.g., Figure 1B-1D , 2b and 3). The open-cell foam 120 is disposed on the outer surface of the sleeve body 102. As described above, the application of negative pressure to the anchoring system 100 and the expansion of the first and second expandable sealing mechanisms 108, 110 form a seal between the first and second expandable sealing mechanisms 108, 110 and the inner surface of the tissue cavity, and generate a friction force that resists the displacement of the sleeve body 102. Figure 2AAlso shown are a series of flexible (or fluid) tubes 125, 127 and 129 and their associated connectors or ports 124, 126, 128, respectively, which are provided for introducing fluid or inflation media (such as, for example, saline, mineral oil, contrast dye, etc.) into the sleeve 116 and / or sleeve body 102 via the flexible tubes or tubing 125, 127, 129 communicating with the corresponding connectors or ports 124, 126, 128.
[0117] Figure 2B Shows Figure 2A An end view of the anchoring system 100 is shown at the proximal end. Figure 2B As shown, the anchoring system includes a first expandable sealing mechanism 108 disposed at a proximal end of the sleeve body 102 (or sleeve 116), the sleeve body 102, the lumen 106, and the sleeve 116 containing various fluid lumens (as discussed further below). Figure 2BAlso shown are a series of flexible (or fluid) tubes 123, 125A, 125B, 127, and 129 and their associated connectors or ports 122, 124A, 124B, 126, and 128, respectively. According to this embodiment, two flexible tubes 125A and 125B are provided, one for each of the first expandable sealing mechanism 108 and the second expandable sealing mechanism 110, to provide a fluid or inflation medium (e.g., saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution) for inflation through its associated connectors or ports 124A, 124B. According to one embodiment, a flexible tube or tubing 127 (such as, for example, an irrigation tube) is provided, which is used to drip fluid (such as, for example, saline) proximal to the anchor portion of the device (if necessary) to liquefy formed feces and maintain the patency of the sleeve body 102 and / or sleeve 116. For example, according to one embodiment, a fluid (such as, for example, saline) can be introduced between the outer surface of the sleeve 116 and the intestinal wall and between the two expandable sealing mechanisms 108, 110 via a flexible tube or tubing 127 in communication with a connector or port 126 from a fluid penetration source (such as, for example, a syringe). According to one embodiment, a flexible tube or tubing 123 in communication with a connector or port 122 can be used to introduce fluid from a fluid penetration source (such as, for example, a syringe). The port 122 can be accessed from outside the patient's body via the flexible tube 123. According to one embodiment, the flexible tube 123 and the port 122 are configured to inject a contrast dye or a radiopaque dye into the distal end of the anchor portion of the device in the intestine to perform a radiographic leak test. According to one embodiment, another flexible tube 129 is provided to deliver a negative pressure source (or vacuum source) to the sleeve body 102 and / or the sleeve 116 via its associated port 128. As described above, the application of negative pressure to the sleeve body 102 and / or the sleeve, and the expansion of the first and second expandable sealing mechanisms 108, 110, form a seal between the first and second expandable sealing mechanisms 108, 110 and the inner surface of the tissue cavity, and generate a friction force that resists the displacement of the sleeve body 102.
[0118] Figure 2C 1 shows an end view of a sleeve 116 including various sleeve lumens according to an embodiment of the present invention. Figure 2CAs shown, sleeve 116 includes (i) a proximal fluid lumen 140 for providing a fluid or inflation medium (such as, for example, saline, mineral oil and / or a dye-based (e.g., iodine-based) contrast solution) to the first expandable sealing mechanism 108 for expansion of the sealing mechanism, (ii) a distal fluid lumen 142 for providing a fluid or inflation medium (such as, for example, saline, mineral oil and / or a dye-based (e.g., iodine-based) contrast solution) to the second expandable sealing mechanism 110 for expansion of the sealing mechanism, (iii) an irrigation lumen 144 for providing a fluid (such as, for example, saline) to irrigate or liquefy feces collected within the lumen 106 of sleeve 116 and / or sleeve body 102, (iv) a negative pressure lumen 145 for providing a negative pressure source to the anchoring system, and (v) a contrast agent lumen 146 for providing a contrast dye to the anchor portion of the device. According to one embodiment, (i) the proximal fluid lumen 140 is in fluid communication with the flexible tube 125A and its associated port 124A, (ii) the distal fluid lumen 142 is in fluid communication with the flexible tube 125B and its associated port 124B, (iii) the irrigation lumen 144 is in fluid communication with the flexible tube 127 and its associated port 126, (iv) the negative pressure lumen 145 is in fluid communication with the flexible tube 129 and its associated port 128, and (v) the contrast lumen 146 is in fluid communication with the flexible tube 123 and its associated port 122. According to one embodiment, the fluid lumens (140, 142, 144, 145, 146) extend the length of the sleeve 116 and are sealed at each end according to their function. For example, according to one embodiment, the proximal and distal fluid lumens (140, 142), contrast lumen (146), negative pressure lumen (145), and flush lumen (144) are sealed at the distal end by a sealed end on the Y-fitting. According to one embodiment, the proximal and distal fluid lumens (140, 142), contrast lumen (146), and negative pressure lumen (145) are sealed at the proximal end by a silicone adhesive encapsulated in the end of each lumen. The flush lumen 144 is typically not sealed at the proximal end to allow fluid to escape.
[0119] Figure 3 The embodiment of the present invention is shown Figure 1A Another illustration of the anchoring system 100. Figure 3As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110 is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to, extending coextensively with, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102. As described above, negative pressure to the anchoring system 100, and expansion of the first and second expandable sealing mechanisms 108, 110, causes a seal to be formed between the first and second expandable sealing mechanisms 108, 110 and the inner surface of the tissue cavity, and generates a friction force that resists displacement of the sleeve body 102.
[0120] Figure 4A The embodiment of the present invention is shown Figure 1A 100, wherein the expandable sealing mechanism is in a collapsed position. Figure 4A As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 in a collapsed position is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110, also in a collapsed position, is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to, coextensive with, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is fluidly connected to the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102.
[0121] Figure 4B The embodiment of the present invention is shown Figure 1A and 4A 1 is a diagram of an anchoring system 100 with the expandable sealing mechanism in an expanded position. Figure 4B As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 in an expanded position is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110, also in an expanded position, is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to the sleeve body 102, extending coextensively with the sleeve body, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102. Figure 4BIn an embodiment of the present invention, the first and second expandable sealing mechanisms 108, 110 are expanded by filling the sealing mechanisms with a fluid or inflation medium (such as, for example, saline, mineral oil and / or a dye-based (e.g., iodine-based) contrast solution) delivered via the proximal and distal fluid lumens, respectively (see, e.g., Figure 2C The proximal fluid lumen 140 and the distal fluid lumen 142 of the catheter are also shown (as discussed in further detail below).
[0122] Figure 5 The embodiment of the present invention is shown Figure 1A An exploded view of each component of the anchoring system 100 is shown. Figure 5 As shown, the anchor system 100 includes a sleeve body 102 that is either (i) attached to the proximal end of a sleeve 116 via the distal end of the sleeve body 102, or (ii) disposed on top of the proximal end of the sleeve 116. Figure 5 As shown, the anchoring system 100 also includes a first (or proximal) expandable sealing mechanism 108 (e.g., a balloon) and a second (or distal) expandable sealing mechanism 110 (e.g., a balloon) and a foam 120. According to an embodiment, the first expandable sealing mechanism 108 is disposed at the proximal end of the sleeve body 102, and the second expandable sealing mechanism 110 is disposed at the distal end of the sleeve body 102, and the open-cell foam 120 is disposed on the outer surface of the sleeve body 102. In some embodiments, as described above, the sleeve body 102 is not present, and the expandable sealing mechanisms 108, 110 and the foam 120 are directly attached to the proximal end of the sleeve 116.
[0123] Figures 6A-6C The method for insertion and anchoring of anchoring system 200 is shown. The anchor portion of anchoring system 200 includes sleeve 220, expandable sealing mechanism 212, 214 and foam dispersed around the sleeve body, which is delivered to the anchoring site through tissue cavity 202. In the case of anastomosis, the device is delivered to the position proximal to the anastomosis so that the sleeve and the sealing mechanism are both proximal to the anastomosis. A semi-rigid tube pusher 203 is used to position the device in the appropriate position. A flexible membrane or protective sheath 204 covers the device and provides coverage and protection of expandable sealing mechanism 212, 214 to reduce friction during placement and prevent damage to the sealing mechanism. The flexible membrane 204 also further reduces friction by covering the foam dispersed on the sleeve body. The device can also be delivered using an endoscope or other delivery system without using a flexible member to cover. An example delivery system is discussed in detail below.
[0124] Once the device is positioned at the desired location above the area that needs to be isolated from the fecal flow by the sleeve 220, it is detached from the delivery system and the delivery system components including the semi-rigid tube pusher 203 and the flexible membrane 204 are removed from the patient. In this regard, according to one embodiment, the flexible membrane 204 is disposed through the central lumen of the device 206 and emerges from the distal end or tip of the device 206 so as to cover and protect the expandable sealing mechanisms 212, 214 and the foam dispersed around the sleeve body. The opposite end of the flexible membrane 204 is connected to a handle (see, e.g., Figures 10A to 10D ), which allows the flexible membrane 204 to be removed by pulling it through the central lumen, thereby uncovering and exposing the expandable sealing mechanisms 212, 214 and the foam dispersed around the sleeve body (see also, e.g., below with respect to Figures 10A to 10J description).
[0125] Figure 6B A device 206 is shown in which the flexible membrane or protective sheath 204 is removed, and the inflatable sealing mechanisms 212, 214 are inflated by filling with a fluid or inflation medium such as, for example, saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution. In some embodiments, the flexible membrane 204 is removed through the center of the semi-rigid tube pusher 203. Figure 6C The device 208 is shown once negative pressure is applied through the pressure lumen 210 and the inflatable sealing mechanisms 212, 214 are filled with a fluid or inflation medium (such as, for example, saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution). As air is removed from the space between the inflatable sealing mechanisms 212, 214 on the outer surface of the sleeve body, the inner wall of the tissue cavity is pulled toward the sleeve body. Figure 6B As shown, the device 206 may have some or all of its components with an outer diameter that is smaller than the inner diameter of the isolated tissue cavity inner wall 215, 217 to which it is anchored. Once inflated, the expandable sealing mechanisms 212, 214 also form a seal with the walls of the tissue cavity at both ends of the sleeve body. Figure 6B and 6CAs shown, once expanded, the expandable sealing mechanism 212, 214 includes an expansion sealing element 222, 224, which is configured to conform to the inner wall 216, 218 of the tissue cavity when negative pressure is applied, thereby producing a liquid-tight and gas-tight seal. The flexibility of the expansion sealing elements 222, 224 and the angles at which they protrude allow them to conform when negative pressure is applied to avoid pressure ischemia of the intestinal wall. This allows the expansion sealing elements 222, 224 to lie flat against the tissue surface, producing a seal with reduced pressure on the tissue at the interface between the expandable sealing mechanism 212, 214 (or the expansion sealing element 222, 224) and the tissue cavity wall 216, 218. The expansion of the expandable sealing mechanism 212, 214 also provides the ability to adapt to irregularities in the contour of the internal tissue cavity wall 216, 218. In addition, the outer diameter of the expandable sealing mechanism 212, 214 is greater than the outer diameter of the foam. This allows a more reliable seal to be formed with the intestine as the intestinal wall is sucked down during negative pressure activation.
[0126] The sealing at both ends of sleeve and / or sleeve body prevents air from entering the space between sleeve and / or sleeve body and cavity wall. The expandable sealing mechanism 212 at the proximal end of sleeve body (or sleeve) also guides the fluid and other GI contents traveling through the tissue cavity to the central lumen of sleeve when the tissue cavity is intestinal. The GI contents pass through the central lumen and enter the sleeve 220. Therefore, the GI contents are isolated from the anastomosis more distally in the GI tract. This prevents the contamination of the anastomosis by feces flow. The expandable sealing mechanism 212,214 and the negative pressure combination produce the gas-tight and fluid-tight bypass of the GI contents, which is better than other methods that have been used to attempt to produce effective sealing at the proximal end of the bypass sleeve in the cavity.
[0127] Fig. 7A The embodiment of the present invention is shown Figure 1A and 4A 1 is a diagram of an anchoring system 100 with the expandable sealing mechanism in an expanded position. Fig. 7A As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 in an expanded position is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110, also in an expanded position, is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to the sleeve body 102, extending coextensively with the sleeve body, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102. Fig. 7AIn an embodiment of the present invention, the first expandable sealing mechanism 108 is expanded (or inflated) by filling the sealing mechanism with a fluid or inflation medium (such as, for example, saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution), which is delivered to the first expandable sealing mechanism 108 via the proximal fluid lumen 140 through a proximal inlet 150 that is in fluid communication with the first expandable sealing mechanism 108.
[0128] Figure 7B The embodiment of the present invention is shown Figure 1A , 4A 7A and 7A are diagrams of the anchoring system 100, wherein the expandable sealing mechanism is in an expanded position. Figure 7B As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 in an expanded position is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110, also in an expanded position, is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to the sleeve body 102, extending coextensively with the sleeve body, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102. Figure 7B In embodiments of the present invention, the second expandable sealing mechanism 110 is expanded (or inflated) by filling the sealing mechanism with a fluid (such as, for example, saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution), which is delivered to the second expandable sealing mechanism 110 via the distal fluid lumen 142 through a distal inlet 152 that is in fluid communication with the second expandable sealing mechanism 110.
[0129] Figure 8 The embodiment of the present invention is shown Figure 1A and 4A 1 is an illustration of an anchoring system 100 in which the expandable sealing mechanism is in an expanded position and provides a contrast agent lumen. Figure 8 As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 in an expanded position is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110, also in an expanded position, is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to the sleeve body 102, extending coextensively with the sleeve body, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102. Figure 8In an embodiment of the present invention, a contrast agent lumen 146 is provided to allow injection of contrast dye or radiopaque dye to perform radiographic leak testing. Figure 8 In an embodiment of the present invention, a contrast lumen 146 is provided to inject contrast dye or a radiopaque dye into the intestine via the outlet port 154 distal to the anchor portion or sleeve body 102 of the device to perform a radiographic leak test.
[0130] Fig. 9 The embodiment of the present invention is shown Figure 1A and 4A FIG. 1 is an illustration of an anchoring system 100 in which the inflatable sealing mechanism is in an inflated position and negative pressure is provided to the anchoring system 100. Fig. 9 As shown, the anchoring system 100 includes a sleeve body 102. A first expandable sealing mechanism 108 in an expanded position is disposed at a proximal end of the sleeve body 102, and a second expandable sealing mechanism 110, also in an expanded position, is disposed at a distal end of the sleeve body 102. A sleeve 116 is in fluid communication with the sleeve body 102 by being connected to the sleeve body 102, extending coextensively with the sleeve body, and / or disposed within the sleeve body, wherein each of the sleeve 116 and the sleeve body 102 is in fluid communication with the lumen 106. An open-cell foam 120 is disposed on an outer surface of the sleeve body 102. Fig. 9 In an embodiment of the present invention, a negative pressure lumen 145 is provided to apply negative pressure (eg, vacuum) to the anchoring system 100. For example, according to Fig. 9 In an embodiment of the present invention, a negative pressure lumen 145 is provided to supply negative pressure to the anchor portion or sleeve body 102 of the device via outlet ports 155, 156, and 157. The application of negative pressure to the anchor portion or sleeve body 102, and the expansion of the first and second expandable sealing mechanisms 108, 110, results in the formation of a seal between the first and second expandable sealing mechanisms 108, 110 and the inner surface of the tissue cavity, and the generation of a friction force that resists displacement of the sleeve body 102 and / or sleeve 116.
[0131] Fig.13 and 14An anchoring system for treating the intestinal wall is shown. In this embodiment, the anchoring system 600 has a first anchoring element 601 at the proximal end of the system, which is placed in the intestine proximal to the area to be treated in the intestine; and a more distal second anchoring element 602, which seals in the intestine beyond the distal area to be treated. There is a port 609 in fluid communication with the sealed closed space between the two anchoring elements and between the intestinal wall and the outer surface of the sleeve, where a fluid or inflation medium (such as, for example, saline, mineral oil and / or a dye-based (e.g., iodine-based) contrast solution) can be introduced or removed to, for example, inflate and deflate an expandable sealing mechanism. A fluid tube 603 in communication with the port 609 can be used to introduce a fluid (e.g., saline) from a fluid infiltration source 605 (such as, for example, a syringe). The port can be accessed from outside the patient's body via the fluid tube 603. This configuration of the device allows for delivery and removal of fluid or inflation media (e.g., saline, mineral oil, and / or dye-based (e.g., iodine-based) contrast solutions) between the outer surface of the sleeve 611 and the intestinal wall and between the two anchor elements 601, 602 for inflation and / or deflation of the expandable sealing mechanism, flushing, medications (e.g., antibiotics, anti-inflammatory drugs, or chemotherapeutic agents), and / or radiological contrast agents. In some embodiments, the more distal second anchor element 602 is shorter than the more proximal first anchor element 601 because the anchoring force of the second anchor element 602 does not need to be as strong and may be required for treatment near the anal verge where a longer anchor element 602 does not fit well within the intestine. The system 600 also includes a pressure tube 612. The pressure tube 612 can be fluidly connected to the outer surface of the sleeve of the first anchor element 601 and the sleeve of the second anchor element 602, such as Fig.13 Alternatively, the system 600 may include two pressure tubes, one for each of the sleeves of the first anchor element 601 and the second anchor element 602. The pressure tube 612 is connected to a pneumatic system 607 configured to apply negative pressure to the pressure tube to anchor the anchor elements 601, 602.
[0132] Fig.14 is a side view of an embodiment of a dual anchor element system, wherein Fig.13Similar reference numerals in the figure represent the same features. This construction is important clinically for many situations, where treatment of isolated intestinal segments may be beneficial. Because this construction allows the therapeutic agent to be controlled and contained in the intestinal lumen for discrete intestinal segments, this embodiment provides a unique ability to provide continuous and localized treatment of the intestinal wall. For example, after endoscopic polypectomy, the resection site can be isolated and treated with local chemotherapy using the disclosed embodiment. Another example can be inflammatory bowel disease, where the affected intestinal segment can have an anti-inflammatory agent delivered and maintained at the disease site. In the case of intestinal wall damage or perforation, an antimicrobial agent can be introduced to reduce the bacterial load during healing and reduce the risk of worsening infection. Depending on the indication and required length of the intestine to be treated, the two anchor elements can be spaced anywhere from about 1 cm to 6 feet. In some cases, the surgeon can manually advance the device from the outside of the intestinal wall when it is open, so very long intestinal segments can be treated, and the upper limit is the length of the entire intestine. This also applies to an anchor element version of the device, because the device can potentially have a sleeve length that can protect the entire intestine.
[0133] This intestinal protection device has several key differences from negative pressure wound therapy devices that can be used in the intestine. The anchoring portion of the disclosed device is not configured to directly treat an area of intestinal injury, wound, or anastomosis. It is configured as a sleeve portion for an anchoring device that protects an area of intestinal injury, wound, or anastomosis. Importantly, the anchor portion of the device is designed to be positioned in the intestine in healthy, undamaged intestine above or proximal to the area of intestinal injury. This approach significantly increases the potential safety of the device because negative pressure is not transmitted to the anastomosis, injury, or injured area; therefore, the protected intestinal area is never ischemic or exposed to significant shear or traction forces from the device.
[0134] It has been demonstrated that negative pressure when delivered to tissue through a sponge interface may reduce blood flow to the area to which it is delivered. Therefore, delivering negative pressure to a damaged area of the intestine itself may further damage the intestine or prevent healing because the blood supply to the intestine is not as strong as other tissues (especially in the area of the anastomosis). In addition, the described method and device have a flexible sleeve covering the area of the intestinal anastomosis or injury; therefore, the anchoring of the device is at a location separate from the area of the damaged tissue. During intestinal contraction in the area of the damaged intestine, less mechanical force is applied to the intestine when contracting around the device, because the flexible sleeve is less mechanically rigid than a negative pressure wound therapy dressing, which uses an internal structure based on a silk stent to keep the lumen open and promote anchoring. In addition, by placing the anchor away from the area of the damaged intestine, the device does not apply mechanical force to the anastomosis or damaged tissue by traction or pulling on the device from the pressure tube or other parts of the device outside the patient's body. No part of the device is anchored distal to the damaged intestine; therefore, traction is only applied to the proximal healthy intestinal tissue. This further reduces the risk of pulling open the anastomotic repair or further damaging the damaged intestinal area.
[0135] Another difference is that the anchoring device described herein must have a much higher pullout strength because it must anchor strongly enough to keep the entire sleeve and anchor element in place in a normally functioning, uninjured intestine. To achieve this, the anchor must be made long enough and wide enough to allow sufficient surface area of sponge contact to prevent expulsion, the anchor and sleeve must be constructed to conform to resist displacement by peristalsis, and the inflatable sealing mechanism must be made stronger to prevent potential air leaks.
[0136] Unlike devices designed to be mechanically displaced over time by intestinal function and peristalsis, the described device is designed to stay in place for an extended period of time until it is removed by the treating clinician. The higher anchoring strength and more secure fixation of the anchoring system 100 is important because it allows the device to be placed near the intestinal site being treated. In the case of a mid-colonic intestinal anastomosis, placing the device higher into the intestine from the anus becomes more challenging due to the curvature of the intestine. Therefore, unlike devices that must be placed higher in the intestine (>40 cm above the area to be treated) due to device migration during the treatment period, the fixed anchoring provided by the disclosed anchoring system allows the anchoring elements (sleeves, expandable sealing mechanisms, and foam) to be placed only a few centimeters above the area to be treated. However, it may be preferred to place the anchoring elements at least 10 cm above the area to be treated to avoid any potential further damage to susceptible intestinal segments.
[0137] This ability to deliver controlled anchoring is achieved through the described design elements described in detail below.
[0138] The following describes in detail the components of the anchoring system according to some embodiments of the present invention. Figure 1A , 2A , 3, 4A and 4B.
[0139] Sleeve body
[0140] According to some embodiments of the present invention, the sleeve body 102 is a flexible concentric tube. In some embodiments, the sleeve body 102 is attached and / or bonded to the outer surface of the sleeve 116 and provides local support in the anchor portion while allowing for more softness and flexibility along the entire length of the sleeve 116. In some embodiments, the sleeve body 102 provides localized increased support to prevent the sleeve 116 and lumen 106 from collapsing under expansion of the expandable sealing mechanisms 108 and 110, as well as increased support to prevent angular displacement of the expandable sealing mechanisms 108 and 110 after expansion. As described below, the sleeve body 102 can be customized to provide higher or lower strength by varying the wall thickness and material hardness.
[0141] When negative pressure is not applied to the outer surface of the sleeve body 102, the outer diameter and profile can be configured to move in the intestine without significant resistance. In some embodiments, the outer diameter of the sleeve body 102 is between 11mm and 61mm on the cross-sectional outer diameter. The inner diameter of the sleeve body 102 determines the diameter of the lumen 106, and in some embodiments, the sleeve body 102 has an inner lumen diameter between 10mm and 60mm on the cross-sectional inner diameter. In order to anchor in other tissue cavities except the intestine, these parameters will be different based on the hollow viscera to be anchored. In some embodiments, the sleeve body 102 may have a diameter greater than or equal to the diameter of the tissue cavity. In some embodiments, the sleeve 116 may have a diameter less than the diameter of the tissue cavity. In some embodiments, the sleeve 116 may have a diameter less than 95% of the diameter of the tissue cavity. In some embodiments, the sleeve 116 may have a diameter less than 50% of the diameter of the tissue cavity. In some embodiments, the sleeve 116 may have a diameter less than 25% of the diameter of the tissue cavity.
[0142] In some embodiments, the sleeve body 102 is configured to be flexible enough to be easily removed by pulling the sleeve 116 to slide the sleeve body 102 out through the intestines and anus, but rigid enough to maintain a concentric shape so that when negative pressure is applied it forms the lumen 106. This allows for easy placement and removal of the device 100. When negative pressure is applied to the outer surface of the sleeve body 102, the sleeve body 102 and the foam 120 surrounding the sleeve body 102 conform to the contours of the GI tract.
[0143] The sleeve body 102 is configured to be soft and pliable, and will not cause erosion into the intestine. The sleeve body 102 has enough flexibility and compliance to allow the proximal end and distal end of the sleeve body 102 to conform to the intestinal contour, so that the foam can be kept during peristalsis to the intestinal wall contact, and the expandable sealing mechanism 108,110 can produce and keep sealing, still keep the concentric tubular shape of the inner lumen 106 open, so that GI contents can pass through. According to some embodiments, the sleeve body 102 includes medical grade silicone, polyurethane, thermoplastic elastomer, rubber or other polymers showing flexibility and rigidity properties described herein. The flexibility of the sleeve body 102 allows it to be safely anchored in the patient's body, because the flexibility of the sleeve body reduces the pressure point produced by the intestinal contraction force. The sleeve body 102 according to some embodiments has a Shore A hardness between about 20A and about 70A, to allow maximum flexibility, while keeping concentric form and open lumen. The flexibility of the sleeve body is also determined by the body wall thickness. The sleeve body 102 is thin-walled, again allowing deformation forces from intestinal peristalsis to act thereon. In some embodiments, the sleeve body 102 has a body thickness between 0.1 mm and 8 mm. Thinness allows the use of more durable materials while continuing to accommodate the peristaltic motion of the intestinal wall.
[0144] The flexibility of the sleeve body 102 allows the sleeve body 102 to deform with the intestine during peristaltic motion. Peristaltic motion moves the contents of the intestine by sequentially compressing the proximal portion of the intestine. Because the device is flexible, it maintains a seal between the expandable sealing mechanisms 108, 110, even when deformed by peristalsis or the passage of intestinal material. It maintains surface contact between the foam 120 and the intestinal wall, and the intestine is able to compress the device, while the device in turn does not exert a large and potentially destructive force on the intestinal wall. Under constant negative pressure maintenance, the negative pressure between the expandable sealing mechanisms 108, 110 produces a more constant normal force during peristalsis along the length of the anchor element, thereby preventing migration by maintaining the foam in relation to the intestinal wall. Therefore, due to the distribution of adhesive forces on the entire surface of the sleeve body 102 covered by the foam interface, the device partially fits and moves with the intestinal wall.
[0145] The flexibility further allows the sleeve body 102 to maintain the position of the foam 120 on the intestinal wall without generating shear forces between the foam 120 and the intestinal wall during intestinal contractions. When the intestine contracts, the flexible sleeve body 102 deforms with the force applied by the attached foam 120, so the foam 120 can more easily deform with the intestinal wall rather than shearing away from the intestinal wall, thereby causing the device to migrate.
[0146] Furthermore, for more flexible anchoring elements, the peristaltic waves have less ability to push against the anchoring element due to flexibility and conformability to contraction. In the case of a more rigid and less conformable body such as a wire-based stent, the peristaltic waves have less resistance to push against the non-deformable body, resulting in device displacement.
[0147] In addition, the flexibility, compressibility and compliance of the disclosed device facilitate placement and removal of the device through the curvature of the intestinal lumen. As the intestine becomes more tortuous and curved, the flexibility allows the device to be delivered further up the digestive tract and allows for easy removal. This flexibility also allows a longer sleeve body 102 with a larger foam 120 surface area and higher resulting anchoring strength to be maneuvered into the intestine. This flexibility is also important for the anchoring system 100 itself, as the foam 120 itself has a higher coefficient of friction than a device without the foam.
[0148] In contrast to the disclosed invention, the stent-like device has a rigidity that resists compression. When the intestine is compressed, this rigidity increases the normal force on the stent and the intestine and causes the stent to slide along the surface of the intestine with the peristaltic waves of normal intestinal contraction. Some stent-based designs do have some compressibility and flexibility, but it is much less than that of the disclosed device. Due to the low hardness construction, thinness, compressibility and conformability of the sleeve body 102 of the device according to some embodiments, the anchor element is more resistant to displacement by peristaltic activity. The flexibility of the sleeve body 102 and the expandable sealing mechanism 108, 110 has a further advantage over more rigid devices, and is easier to operate to be placed in the intestine along the normal longitudinal curvature of the intestinal lumen. In addition, when the device is placed in an intestinal area with a longitudinal curvature, it is easier to conform to the curvature when negative pressure is applied to maintain contact of the foam to the intestinal surface area and prevent pressure points that may damage the intestinal wall. In addition, the elimination of the structure based on the wire stent greatly enhances the manufacturability from the perspective of ease and cost.
[0149] The length of the sleeve body determines the length of the anchoring element, and the length of the anchor portion of the device is also an important characteristic of the device. The anchoring strength of the anchor portion of the device depends directly on the length of the sleeve body 102 and the associated surface area of the foam 120 in contact with the intestinal wall. Just as the diameter affects the surface area of foam contact, the length of the anchor portion also affects. Unlike stents, negative pressure dressings or sheaths, which are located distally in the colon near the anal verge at the anastomotic site or damaged intestinal area, they can be rigidly supported in place by the device and do not need to significantly conform to the proximal intestinal bends in the intestine, and the anchor portion of the system according to some embodiments is constructed in length from more than 3cm to less than 25cm in length window. Tests in a porcine model show that if the length of the anchor device is less than 3cm and the diameter is 33mm, it will not have a surface area to maintain a pull-out strength greater than 5lbs and is susceptible to loss of seal and displacement of low-force devices (<5lbs force). Furthermore, if the length of the anchor portion of the device is longer than 25 cm, the device cannot be easily placed around the anatomical bend of the intestine and positioned in the intended anchoring area above (proximal in the intestine) the level of the intestinal region to be protected. For applications in other tissue cavities requiring less pull-out strength, such as, for example, catheters or esophagus, the length of the device may be shorter than 3 cm. Furthermore, embodiments of the present invention are not limited to flexible sleeves, and stent-like sleeves enclosed in foam may also be used.
[0150] Inflatable sealing mechanism
[0151] The device 100 includes an inflatable sealing mechanism 108, 110 disposed at each end of the sleeve body 102 and / or along the proximal end of the sleeve 116. According to one embodiment, the inflatable sealing mechanism 108, 110 includes two soft, inflatable elastomeric balloons that provide an atraumatic sealing surface to facilitate negative pressure anchoring and provide sealing of different fluids / gases to prevent fecal contamination distal to the anchoring device 100. According to one embodiment, the inflatable sealing mechanism 108, 100 is inflated by injecting a fluid or inflation medium (e.g., saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution) via a syringe connected to the distal and / or proximal ports of the anchoring system 100. The inflatable sealing mechanism 108, 110 contacts the inner surface of the tissue cavity in which the sleeve body 102 and / or sleeve 116 is inserted. The inflatable sealing mechanism 108, 110 provides at least two functions. First, once expanded, they create a seal with the intestinal wall between the proximal and distal ends of the outer surface of the sleeve body 102 to form a negative pressure space in which the foam 120 can be drawn down to the intestinal wall and create an anchoring force. Second, when the inflatable sealing mechanisms 108, 110 expand and negative pressure is applied to the outer surface of the sleeve body 102, the seals form a fluid-tight and gas-tight seal with the inner surface of the tissue cavity at both ends of the sleeve body 102, which directs the GI contents through the lumen 106 of the sleeve body 102 and into the same lumen 106 of the sleeve 116 attached to the sleeve body 102. The expansion of the inflatable sealing mechanisms 108, 110 minimizes the risk of seal breach caused by forward or backward reflux of stool because the stool flow is directed toward the central lumen 106 of the sleeve body 102 through the inflatable sealing mechanisms 108, 110.
[0152] The exact height of each inflatable sealing mechanism 108, 110 is less important than the relationship of the sealing mechanism to the outer diameter of the covering foam 120. In some embodiments, the inflatable sealing mechanism 108, 110 of the system extends beyond the height of the foam 120 when at rest, such that when inflation and / or negative pressure is applied and the intestinal wall collapses, a seal can be easily formed between the inflatable sealing mechanism 108, 110 and the intestinal wall without interference from the foam 120. Thus, when at rest without the application of inflation and / or negative pressure, the annular diameter of the inflatable sealing element 108, 110 is greater than the annular diameter of the foam 120 dispersed over the sleeve body 102. In some embodiments, the inflatable sealing mechanism 108, 110 extends beyond the height of the foam 120 by at least 1 mm when at rest.
[0153] The expandable sealing mechanism 108,110 is made of soft, inflatable and flexible materials, which allow them to expand and conform to the surface of the intestine. This is important, because without this flexibility, the peristaltic force of intestinal contraction can cause potentially harmful pressure points. For example, the expandable sealing mechanism 108,110 may include thermoplastic elastomers, silicones, polyurethanes, rubber or other rubbery materials or polymers. The Shore A hardness of the material can be between about 20A and about 70A. Similar to the low hardness of the sleeve body 102, when expansion and negative pressure are applied and during intestinal peristalsis, the low hardness of the expandable sealing mechanism 108,110 allows compression and conforming to the intestinal lumen during the sealing process. The compliance, flexibility and compressibility of the expandable sealing mechanism 108,110 allow to reduce displacement during peristalsis in a manner similar to the flexibility of the sleeve body, and are easier to place and remove the device.
[0154] The expandable sealing mechanism 108, 110 extends radially beyond the outer diameter of the sleeve body 102 and / or the sleeve 116 to form a seal at each end of the sleeve body 102 and / or along the proximal end of the sleeve 116. The expandable sealing elements 180, 110 extend radially toward the inner surface of the tissue cavity. In some embodiments, the expandable sealing elements 108, 110 extend radially beyond the foam 120 before and / or after expansion, allowing the sealing to occur at the ends of the sleeve body 102 and / or the sleeve 116 without interference from the foam 120. Each expandable sealing mechanism 108, 110 can be a single sealing element or a plurality of sealing elements. The expandable sealing element is an expandable element that provides a gas-tight and fluid-tight seal and is configured to conform to the GI tissue to produce one or more local gas-tight and fluid-tight seals.
[0155] The inflatable sealing mechanism 108, 110 can be configured to be attached concentrically around the outer surface of the sleeve body 102 and / or sleeve 116, or can be integrated into the wall of the sleeve body 102 and / or sleeve 116. Specifically, this relates to the manufacturing process for forming the anchor portion, because the inflatable sealing element can be made in one mold with the sleeve body 102 and / or sleeve 116, or they can be molded separately and bonded to the sleeve body 102 and / or sleeve 116. According to some embodiments, the inflatable sealing element 108, 110 and the sleeve body 102 and / or sleeve 116 are created as a single molded part because the two elements of the device have similar material property requirements of strength, flexibility and conformability. In some embodiments, the sleeve body 102 and / or sleeve 116 and the inflatable sealing mechanism 108, 110 are made from a single mold using the same material.
[0156] In some embodiments, the sleeve body 102 and / or sleeve 116 are divided into a plurality of anchoring sections with independent negative pressure supply. An anchoring section is a section of an independently anchored sleeve along the sleeve. In some embodiments, the sleeve body 102 and / or sleeve 116 are divided into one or more additional anchoring section elements independently anchored to the intestinal wall to produce two or more sealed isolation areas along the sleeve. Foam is placed between each sealed isolation section to distribute pressure and engage with the intestinal wall interface. Negative pressure is applied to the space between the seals while expanding each expandable sealing mechanism to produce redundant areas anchored along the length of the sleeve body and / or sleeve. In some configurations, negative pressure is applied to each section from an independent negative pressure source while each sealing mechanism is expanded by one or more expansion and / or inflation sources. In some configurations, these sections share the same negative pressure source and / or the same inflation source. Similar to having multiple anchoring elements, this embodiment provides redundancy in the anchoring system. An advantage of this design is that if the seal in one segment fails, there is still bonding / anchoring force at another segment or segments.
[0157] Sleeves, extension tubes and collection bags
[0158] Device 100 includes sleeve 116, which in some embodiments is connected to sleeve body 102, coextensive with sleeve body and / or disposed in sleeve body and is in fluid communication with sleeve body 102. According to some embodiments, sleeve 116 is directly connected to sleeve body 102. According to some embodiments, sleeve 116 is indirectly connected to sleeve body 102. For example, sleeve 116 can be connected to second expandable sealing mechanism 110 at the distal end of sleeve body 102. In some embodiments, sleeve and sleeve body are single tubular structures. For example, sleeve 116 can also be sleeve body 102 by dispersing two expandable sealing elements 108, 110 and foam 120 on the proximal end of sleeve 116, without a separate sleeve body. Sleeve 116 shares the same lumen 106 with sleeve body 102. Expandable sealing mechanisms 108, 110 guide GI contents into sleeve body 102. When the GI contents reach the distal end of the sleeve body 102, they continue to pass through the lumen 106 of the sleeve 116. The sleeve 116 may have a length sufficient to extend from the distal end of the sleeve body 102 to the anal canal of the patient, and to the outside of the patient's body. Therefore, once the GI contents enter the sleeve body 102, it is guided into the sleeve 116 and is completely isolated from the inner surface of the patient's intestine at the distal end of the sleeve body 102. The sleeve 116 forms a barrier between the GI fecal flow contents and the intestinal wall, thereby protecting this portion of the intestine. In order to isolate the intestinal wall from the fecal flow contents, the sleeve 116 should be substantially impermeable to fluids. Secondly, the sleeve 116 also mechanically shields the intestinal wall from the mechanical expansion force of the GI flow contents.
[0159] According to some embodiments, sleeve 116 is coupled to sleeve body 102 or distal (second) expandable sealing mechanism 110. Sleeve 116 may have a molded fixed attachment configured to lock into sleeve body 102 or distal sealing mechanism 110. According to some embodiments, sleeve 116 is made of a non-degradable biocompatible material. For example, sleeve 116 may be made of silicone, polyurethane, thermoplastic elastomer, rubber or other polymers, although embodiments of the present invention are not limited to these materials. Sleeve 116 should be substantially impermeable to fluids and bacteria.
[0160] Sleeve 116 is configured so that its diameter allows it to stay in the GI tract without hindering the GI flow material from flowing through it. In some embodiments, sleeve 116 has a cross-sectional diameter between about 10mm and about 60mm. The sleeve is made of suitable material and is thin and compliant enough so that sleeve 116 can be compressed by the intestinal wall and does not eliminate the effect of peristaltic motion on fecal flow. Different from semi-rigid drainage tubes (which are mainly designed to remain open and rely on gravity and gastrointestinal flow pressure to move GI contents down along the tube), the sleeve according to some embodiments is deformable during peristalsis to allow serial compression to move GI contents down along the sleeve. This allows the device to be placed more proximally in the intestine because gravity and GI flow pressure are not enough to move the material through a longer sleeve length, because the flow resistance increases with the increase of sleeve length. In addition, this compliance and associated flexibility allow navigation around intestinal bends, improve patient comfort, reduce the chance of intestinal wall damage / erosion, and prevent sleeve blockage. Some embodiments of sleeve 116 have a wall thickness between about 50 microns and 5mm. In some embodiments, the length of sleeve 116 is sufficient to extend beyond the GI tract to the anal canal after the device is placed. In some embodiments, the length of sleeve 116 is between about 8 inches and 72 inches. In some embodiments, the device is configured so that traction of sleeve 116 from outside the body can be used to remove the device from the body cavity. Sleeve 116 must be strong enough to withstand longitudinal traction of at least 10 lbs of force without tearing, so that the sleeve can be used to remove the device after the treatment is completed. In some embodiments, sleeve 116 is marked with an indicator along its length, which shows the length of sleeve 116 located in the GI tract or tissue cavity after being placed in the intestine or other tissue cavity. The user can use the indicator to determine whether the anchor portion is migrating. Sleeve 116 according to some embodiments has a fixed length. According to some embodiments, the length of sleeve 116 can be adjusted by cutting sleeve 116.
[0161] According to one embodiment, the sleeve 116 is connected or anchored to an optional extension tube that can be attached for bedside use. Fig.12 FIG. 5 shows an extension tube 500 according to an embodiment of the present invention. Fig.12As shown, the extension tube 500 includes an inlet or proximal end 502 having an inlet connection 512, which can be used to connect to the distal end of the sleeve 116. The extension tube 500 also includes a tube 510 extending from the inlet or proximal end 502 to an outlet or distal end 504. The outlet or distal end 504 includes an outlet connection 514 and one or more connecting members 516 for attaching the extension tube 500 to another member and / or a collection bag. According to one embodiment, the extension tube 500 extends the length of the device sleeve 116 to a collection bag (described below) for bedside use. According to one embodiment, the extension tube 500 allows the ICD device to be easily removed at the bedside or in an outpatient clinic without the need for additional invasive procedures.
[0162] According to some embodiments of the present invention, a collection bag is provided at the distal end of the sleeve 116 and / or the extension tube 500 to manage the intestinal (or GI) contents passed from the sleeve 116. The collection bag is airtight and leakproof and has sufficient volume to accommodate at least one day's use and has a provision for emptying the contents. The collection bag is attached to the sleeve 116 and / or the extension tube (see, e.g. Fig.12 The collection bag is made of a material that is resistant to GI contents, provides an odor barrier, and is biocompatible for use with direct skin contact. The collection bag is supplied sterile in a disposable peel-open bag.
[0163] According to one embodiment, Figures 20A-20B As shown in Figures 21A-21B, the collection bag 1300, 1400, which can be attached to the end of the sleeve 116 and / or the distal end 504 of the extension tube 500, includes an inlet end or connection 1302, 1402, which is attached to the end of the sleeve 116 and / or the distal end 504 of the extension tube 500. The inlet end or connection 1302, 1402 of the collection bag 1300, 1400 is connected to a neck portion 1304, 1404, which is in turn attached to a bag portion 1305, 1405 of the collection bag 1300, 1400, which collects GI contents that flow through the sleeve body 102 and the sleeve 116. The bag portion 1305, 1405 transitions to an outlet end 1310, 1410, at which the collected GI contents can be emptied from the collection bag 1300, 1400. As shown in Figures 21A-21B, the collection bag 1300, 1400 can be attached to the neck portion 1304, 1404, which is in turn attached to the bag portion 1305, 1405 of the collection bag 1300, 1400. Figures 20A-20B21A-21B, the bag portion 1305, 1405 tapers to an outlet end 1310, 1410. The collection bag 1300, 400 may also include a plurality of markings 1306, 1406 to measure the amount of GI contents that have been collected. In addition, the collection bag 1300, 1400 may include one or more openings 1308, 1408 that allow the collection bag 1300, 1400 to be attached to a patient and / or a bed.
[0164] Fig. 20A Also shown is a drain clamp 1320 that can be used to clamp or seal the outlet end 1310 of the collection bag 1300 until the collected GI contents are emptied from the collection bag 1300 via the outlet end 1310 . Fig. 20B A pair of attachment straps 1330, 1340 are shown that are positionable within one or more openings 1308, 1408 of the bag portion 1305, 1405 of the collecting bag 1300, 1400 to attach the collecting bag 1300, 1400 to a patient and / or a bed.
[0165] The collection bags 1300, 1400 should be substantially impermeable to air and fluid. The collection bags 1300, 1400 collect GI contents flowing through the sleeve body 102 and the sleeve 116. In some configurations, the sleeve 116 terminates in a port that can remain closed for continence and open to be emptied. In other configurations, the sleeve 116 is flexible enough to allow the anal sphincter to compress the sleeve and provide continence. In this configuration, the collection bag may not be used. According to some embodiments, the collection bag may be removed and replaced as needed. In some embodiments, the collection bag may be constructed with a connecting attachment that allows the length of the sleeve to be cut and a seal with the bag to be reestablished. In some embodiments, the collection bag has a mark (see, e.g., mark 1306, 1406) so that the outflow can be determined. In some embodiments, the collection bag has a leg band (see, e.g., attachment band 1330, 1340) for attaching the collection bag to the patient's body. In some embodiments, the collection bag may also include a port to prevent any excessive accumulation of gas. According to some embodiments, the external collection bag contains a one-way valve that prevents the collected GI contents from flowing back into the sleeve. In some embodiments, the collection bag has elastic leg straps (see, e.g., attachment straps 1330, 1340) that secure the collection bag to the patient's body.
[0166] Foam and / or air conducting rough surface materials
[0167] The device 100 includes a foam 120 disposed on the outer surface of the sleeve body 102. The foam 120 or foam-like material (e.g., an air-conducting rough surface material) plays a key role in increasing anchoring strength and preventing damage to the intestine. When suction is applied to the outer surface of the sleeve body 102, the foam 120 provides a critical friction force to keep the sleeve body 102 in place. In addition, the foam 120 distributes negative pressure and force to minimize pressure points that may damage the intestine.
[0168] The foam 120 dispersed on the sleeve body 102 and / or the sleeve 116 provides a high friction coefficient material with a maximum surface area, wherein adhesion is generated by utilizing the normal force generated by the negative pressure. Foam and / or air-conducting rough surface materials are the best materials for distributing negative pressure in the present application and providing an effective friction coefficient when the negative pressure is applied. It is conceivable to use a device using a membrane, wherein the membrane has a series of holes placed very close to form a porous membrane to distribute the negative pressure. However, the normal force generated by the membrane-based device is limited by the open surface area generated by the holes. In addition, the porous membrane has a much lower friction coefficient than the rough surface of the foam and / or air-conducting rough surface material. The foam and / or air-conducting rough surface material also has a larger surface area for effective contact with the intestine, due to its open cell structure and multiple holes for distributing negative pressure throughout its material. In order to maintain a comparable pull-out strength without foam (or air-conducting rough surface material), the size of the required negative pressure will have to be increased and significant point stress will be placed on the intestine.
[0169] The foam 120 and / or the air-conducting rough surface material include materials selected to produce specific compression characteristics and friction coefficients to prevent migration of the sleeve body 102 and / or the sleeve 116. The foam 120 and / or the air-conducting rough surface material may include a material with a pore size that allows negative pressure to be distributed throughout the foam while preventing tissue from growing into the foam. When normal pressure is restored, this allows the foam 120 and / or the air-conducting rough surface material to be easily displaced from the inner surface of the tissue cavity. In order to have the characteristics required to distribute negative pressure and generate high friction, some embodiments of the foam 120 and / or the air-conducting rough surface material have an average foam pore size between about 50 microns and about 1000 microns in diameter. In some embodiments, the average pore size of the foam 120 and / or the air-conducting rough surface material is between about 100 microns and 300 microns. In some embodiments, the average pore size of the foam 120 and / or the air-conducting rough surface material is between about 200 microns and 400 microns. In some embodiments, the average pore size of the foam 120 and / or the air-conducting rough surface material is between about 300 microns and 600 microns. With too small a pore size, the foam 120 and / or the air-conducting rough surface material loses some of its frictional capabilities, and with too large a pore size, the material may have tissue ingrowth and have a lower tear strength. In some embodiments, the density and material composition of the foam 120 and / or the air-conducting rough surface material must allow the foam to have an overall tensile strength of at least about 50 KPa. This allows deformation forces and traction on the sleeve body 102 without shearing or tearing the foam 120 and / or the air-conducting rough surface material. Because the foam 120 and / or the air-conducting rough surface material is subject to shear forces applied to the anchoring system 100, the foam must have a high tear force capable of withstanding a shear force of about 50 KPa and must be secured to the sleeve body 102 in a manner capable of withstanding a separation force of about 50 KPa without separating. The level of force exerted on the device by peristalsis and the expulsion forces on the sleeve body 102 and sleeve 116 is much higher than that used to hold a piece of foam in place to treat a small wound area as may be done with negative pressure wound therapy.
[0170] In some embodiments, the foam 120 and / or the air-conducting rough surface material is composed of a hydrophilic material that prevents the foam from drying the surface tissue it contacts, although hydrophobic materials may also be used in some embodiments. According to some embodiments, the foam 120 and / or the air-conducting rough surface material comprises polyvinyl alcohol. In some embodiments, the foam 120 and / or the air-conducting rough surface material is made of polyurethane, another polymer, or an organic fiber web. In some embodiments, the open-cell foam 120 comprises a single tubular foam piece.
[0171] The foam 120 and / or air-conducting rough surface material covers the outer surface of the sleeve body 102 and / or sleeve 116, and generates frictional forces that resist the movement of the sleeve body 102 and / or sleeve 116 relative to the intestine when negative pressure is applied to the outer surface. The porosity of the foam 120 and / or air-conducting rough surface material allows air to be discharged from the area between the outer surface of the sleeve body 102 and the inner surface of the tissue without strong suction being applied to any single point. This creates frictional forces that are evenly distributed on the outer surface of the foam 120 and / or air-conducting rough surface material. The foam 120 and / or air-conducting rough surface material under negative pressure also creates a large surface area where frictional forces are generated to resist displacement. The foam 120 and / or air-conducting rough surface material is designed to be compressible to minimize the amount of force applied to any single point of the intestine when negative pressure is applied, and to maximize surface area contact with the intestinal wall by conforming to the shape of the intestinal wall.
[0172] In some embodiments, the foam 120 and / or air-conducting rough surface material dispersed on the sleeve body 102 and / or sleeve 116 must have a thickness or height that allows for the dispersal of negative pressure around the sleeve body 102 and / or sleeve 116, but does not extend beyond the height of the radial edges of the inflatable sealing mechanism 108, 110 at rest and / or after expansion, or cause the sleeve lumen 106 to narrow to the point of impeding the flow of GI contents. If the foam 120 and / or air-conducting rough surface material is too thin, it will collapse or clog and not have enough open cells to evenly distribute negative pressure around the sleeve body 102 and / or sleeve 116. If the foam and / or air-conducting rough surface material is too thick, it will prevent a gas-tight seal from initiating at the inflatable sealing mechanism 108, 110 and contract the diameter of the sleeve lumen 106. In some embodiments, the thickness of the foam 120 and / or air-conducting rough surface material disposed around the sleeve body 102 and / or sleeve 116 is between 2 mm and 1.5 cm.
[0173] According to some embodiments, the foam 120 and / or the air-conducting rough surface material can be segmented into separate subunits. In some embodiments, multiple foam pieces are dispersed around each anchoring segment. As described above, these segments can be separated by multiple series sealing elements. In these embodiments, negative pressure can be applied to all subunits in parallel or separately by independent negative pressure supplies.
[0174] In some embodiments of the disclosed invention, alternatives to foam can be used to form an interface with the intestinal wall. These foam-like alternatives include, for example, air-conducting rough surface materials, which must evenly distribute negative pressure through the material, generate significant friction when negative pressure is applied to resist displacement, have biocompatibility with the tissues of the GI tract, and compressibility and deformation properties that resist tissue damage caused by discharge and pressure. Some potential polymer-based alternatives or air-conducting rough surface materials are stacked mesh matrices wrapped around a sleeve or sleeve body, honeycomb grids of interconnected channels oriented in a radial manner around a sleeve or sleeve body, or 3-D woven synthetic fabric materials. Natural fiber substitutes include gauze, naturally occurring sponges, or woven fabrics. However, some embodiments of the device utilize open-cell reticulated foam. According to one embodiment, the air-conducting rough surface material has an average pore size between about 200 microns and 400 microns. According to some embodiments, the air-conducting rough surface material has a higher coefficient of friction than the sleeve 116 and / or the sleeve body 102.
[0175] Pneumatic system
[0176] According to one embodiment, the device 100 includes a pressure tube (not shown) that is fluidly connected to the outer surface of the sleeve body 102 and / or sleeve 116. The pressure tube is connected to a negative pressure source, such as an air pump or vacuum, which sucks air out of the tube in a controlled manner. The pump maintains a constant or variable negative pressure at a certain pressure level that allows sufficient anchoring so that the anchor portion does not become displaced, but does not damage the intestine. The construction of the device allows a physiologically safe pressure of up to -200 mmHg, although a pressure of -50 mmHg to -150 mmHg may be a preferred range for negative pressure delivery. After the seal is formed by the expansion of the expandable sealing mechanism 108, 110 at both ends of the sleeve body 102, negative pressure is applied to the tube. When the pressure tube connected to the negative pressure source continues to apply negative pressure, the inner wall of the tissue cavity is pulled toward the outer surface of the sleeve body 102 and / or sleeve 116, bringing the tissue into contact with the foam 120. The normal force generated by the negative pressure sucking the tissue down onto the foam 120 generates a friction force that resists the movement of the sleeve body 102. The pressure tube is configured to resist blockage from wall collapse when negative pressure is applied. In some embodiments, there is more than one pressure tube to provide redundancy in the event of a kink or blockage of any one pressure tube. In some embodiments with multiple pressure tubes, a more flexible and compliant tube material can be used due to the redundancy of negative pressure transmission. Each of these pressure tubes is individually connected to the foam 120 fluid to allow negative pressure delivery. In some embodiments, where there are multiple anchoring portion elements or where there are multiple anchoring portion segments, there may be a separate pressure tube connected to each anchoring portion element or anchoring portion segment. Multiple pressure tubes may be connected to a single negative pressure source, such as a single pump, or individually connected to multiple pressure sources, such as multiple pumps.
[0177] According to one embodiment, a pressure tube (not shown) extends from the sleeve body 102 beyond the anus. The pressure tube can be disposed within the wall of the sleeve 116 or be separate. According to some embodiments, the sleeve 116 defines an additional lumen in which the pressure tube is disposed so that it is isolated from GI contents traveling through the sleeve 116. Alternatively, the pressure tube can be located alongside the sleeve 116, or attached to the exterior of the sleeve 116, the interior of the sleeve 116, or separate from the sleeve 116. In another embodiment, the additional lumen in the sleeve 116 is a pressure tube (see, e.g., Figure 2C negative pressure lumen 145).
[0178] The proximal end of the pressure tube may be connected to the distal end of the sleeve body 102 or to a second expandable sealing mechanism 110 disposed at the distal end of the sleeve body 102 .
[0179] According to some embodiments, the pressure tube is part of the pneumatic system that controls the pressure on the outer surface of the sleeve body 102 and / or sleeve 116. The pneumatic system includes a pump that draws air out of the pressure tube and maintains a near constant and / or variable negative pressure at a set pressure level in the range of -50mmHg to -200mmHg. Bench tests have shown that a -50mmHg negative pressure to the system can produce a longitudinal pull-out force of >10lbs. The pneumatic pump can also be able to apply positive pressure in some configurations, for example to help the device be removed from the patient's intestines. The pneumatic pump can maintain negative pressure by an electric pump mechanism or a mechanical pump mechanism. The pneumatic system may include an indicator that allows the user to determine whether sufficient negative pressure has been reached and maintained. For example, a pressure gauge may be an indicator that indicates that a seal is maintained when the suction force is measured in the pneumatic system.
[0180] In some embodiments, the pressure tube has an adapter that can be used to attach a syringe so that the pressure tube can be flushed and the foam 120 flushed with fluid. This can help remove the device from the intestinal wall during the removal process, or be used to flush GI contents that may block the pneumatic system away from the foam interface.
[0181] Insertion and Removal
[0182] During insertion into the patient's intestine, the device 100 is introduced into the anal canal and moved past the anastomotic site so that the second expandable sealing mechanism 110 disposed at the distal end of the sleeve body 102 is proximal to the anastomosis. The deployment method depends on the level of the anastomosis. For low anastomosis, the device can be deployed by a manually positioned capsule sheath system. For higher anastomosis, an endoscope can be used to assist in deployment. The device can be placed on the outside of the endoscope and fixed so that the user can position and deploy the device at a desired location.
[0183] According to some embodiments, the anchoring system 100 is configured to be placed into the appropriate position through an endoscope. The device 100 may have a suture or tab present that can be grasped by an endoscopic grasper to pull the sleeve body 102 into the appropriate position using the endoscope. In some embodiments, the device is attached to a releasable clip on the end of the endoscope, which can release the device from the end of the endoscope outside the body. Alternatively, the endoscope can be used to hold a flexible member attached to the anchor, such as a wire or rope, which is looped out of the patient's body and pulled around the fixed end of the endoscope in the intestine to pull the device into the intestine and into the desired position. As discussed in further detail below, the device 100 can be attached to the intestine via a scope adapter (see, e.g., FIG. 15A to FIG. 18 ) connected to the endoscope.
[0184] In some embodiments, sleeve 116 can be attached to the endoscope using a clamping mechanism that can be released from the outside of the body. In some embodiments, sleeve 116 can be attached to a semi-rigid tube that fits on the endoscope. The tube is configured to push the anchoring system 100 to the appropriate position on the endoscope and then release it from the anchoring system 100. In other embodiments, the introduction member is a first semi-rigid tube that accommodates the proximal end portion of the device. The first semi-rigid tube is pushed into the intestine through the anus, and after reaching the desired position, a second semi-rigid push tube that surrounds the sleeve and is smaller in diameter than the first semi-rigid tube is used to keep the device in place while removing the first semi-rigid tube. The second semi-rigid push tube is then removed after the negative pressure anchoring of the anchoring system 100 begins.
[0185] Figures 10A-10E FIG. 3 shows an ICD delivery system 300 according to one embodiment of the present invention. Fig. 10A As shown, the ICD delivery system 300 includes a handle 306, a guide shaft 303, an outer protective sheath (see, e.g. Fig. 10BThe ICD delivery system 300 includes a sheath 320 in the anus and a sheath puller 307, which allows a doctor or surgeon to place an ICD device during, for example, a colon resection. The ICD delivery system 300 facilitates the placement of the ICD device by maintaining a small anchor profile during insertion and protecting the expandable sealing mechanism (i.e., an expandable elastomeric balloon) from potential damage when the device is inserted through a stapled anastomosis. To facilitate placement through the pelvic flexure, in some embodiments, the guide shaft 303 may have a slight bend at the leading insertion end. The ICD device is inserted, advanced, and positioned transanally with the ICD delivery system 300. A water-based lubricant, such as, for example, KY-Jelly, is used to facilitate placement. The anchor portion is positioned 5 to 10 cm above an area (e.g., an anastomosis after rectal cancer surgery) that needs protection from fecal flow (e.g., more proximal in the GI tract). Importantly, the anchor portion of the device is designed to be placed in healthy intestines, not in damaged intestinal areas that need protection. After positioning the anchor, the outer protective sheath is removed by withdrawing the outer protective sheath using the sheath puller 307. The device is then ready for deployment.
[0186] Fig. 10B and 10C The anchoring system 100 described above is shown in combination with Fig. 10A ICD delivery system 300. Fig. 10B and 10C As shown, the anchoring system 100 includes a sleeve body 102, first and second expandable sealing mechanisms 108, 110 disposed on the sleeve body 102, a foam 120 dispersed on the sleeve body 102, and a sleeve 116 connected to the sleeve body 102, wherein a sheath 320 of the ICD delivery system 300 is disposed on the proximal end of the anchoring system 100 or the sleeve body 102 to protect the sleeve body 102 during insertion of the anchoring system 100 into the patient's body. A guide shaft 303 attached to a handle 306 is positioned inside the sleeve 116 and the sleeve body 102 so as to push the anchoring system 100 into a suitable position within the anal canal.
[0187] Fig. 10D Shows Figures 10A-10C FIG. 3 is an enlarged partial cross-sectional view of the distal end or handle portion of the ICD delivery system 300. Fig. 10D As shown, the guide shaft 303 is attached to a handle 306, wherein the handle 306 has a plurality of ridges 316 to help the user or physician grasp the handle 306. A sheath pull handle 307 interacts with the handle 306 and is further attached to an inner portion 322 of the sheath 320 (see, e.g., Fig. 10B and 10C ) to remove the sheath 320 from the proximal end of the anchoring system 100 or sleeve body 102 by pulling the sheath pull handle 307 in the distal direction.
[0188] Fig. 10EShows Figures 10A-10C FIG. 3 is a partial enlarged cross-sectional view of the proximal end of the ICD delivery system 300. Fig. 10E As shown, the sheath 320 is disposed on the proximal end of the anchoring system 100 or sleeve body 102, which includes the first and second expandable sealing mechanisms 108, 110 and the foam 120. The guide shaft 303 attached to the handle 306 is positioned inside the sleeve 116 and the sleeve body 102 to push the anchoring system 100 into place within the anal canal. Fig. 10E As further shown, the sheath 320 extends to an attachment portion 325 and an inner portion 322, which are attached to the sheath pull handle 307 so as to remove the sheath 320 from the proximal end of the anchoring system 100 or the sleeve body 102 by pulling the sheath pull handle 307 in the distal direction, as described above. When the sheath pull handle 307 is pulled in the distal direction, the sheath 320 is removed from the outer surface of the sleeve body 102 including the first and second expandable sealing mechanisms 108, 110 and the foam 120, and is pulled through the lumen 106 of the sleeve body 102 and the sleeve 116, and thereafter away from the device. This removal of the sheath 320 typically occurs once the anchoring system 100 is placed in place within the anal canal via the guide shaft 303.
[0189] Figures 10F-10J The embodiment according to the present invention is shown Fig. 10E The anchoring system shown along with the delivery system Fig. 10E For example, Fig.10F It is along Fig. 10E The line AA is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown. Fig.10F As shown in the embodiment of FIG. 1 , the end of the anchoring system 100 having the delivery system 300 includes a sheath 320 positioned around the first expandable sealing mechanism 108 , the sleeve body 102 , an attachment portion 325 of the sheath 320 , and a guide shaft 303 .
[0190] Figure 10G It is along Fig. 10E The line BB intercepts Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown. Figure 10G In an embodiment of the present invention, a portion of the anchoring system 100 is shown together with a delivery system 300, which includes a sheath 320 positioned around the first expandable sealing mechanism 108, the sleeve body 102, the sleeve 116, an attachment portion 325 of the sheath 320, and a guide shaft 303.
[0191] Fig. 10H It is along Fig. 10E The line CC is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown. Fig. 10HIn an embodiment, a portion of the anchoring system 100 is shown along with a delivery system 300, which includes a sheath 320 positioned around the foam 120, a sleeve body 102, a sleeve 116 (which includes an outlet 330 located in one of the sleeve lumens), one of the fluid lumens 345, an inner portion 322 of the sheath 320, and a guide shaft 303.
[0192] Fig.10I It is along Fig. 10E The line DD is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown. Fig.10I In an embodiment, a portion of the anchoring system 100 is shown together with a delivery system 300, which includes a sheath 320 positioned around a second expandable sealing mechanism 110, a sleeve body 102, a sleeve 116, one of the fluid lumens 345, an inner portion 322 of the sheath 320, and a guide shaft 303.
[0193] Fig.10J It is along Fig. 10E The line EE is intercepted as Fig. 10E A cross-sectional view of the anchoring system together with the delivery system is shown. Fig.10J In the embodiment of FIG. 1 , a portion of the anchoring system 100 is shown along with a delivery system 300 that includes the sleeve 116 , one of the fluid lumens 345 , the inner portion 322 of the sheath 320 , and the guide shaft 303 .
[0194] Figures 11A-11D FIG. 4 shows an ICD delivery system 400 according to another embodiment of the present invention. Fig.11A and 11B As shown, the ICD delivery system 400 includes a handle portion 404, a guide shaft 405, an outer protective sheath (not shown) that extends the length of the anchoring system and / or the ICD delivery system 400 (see, e.g. Fig. 11CThe ICD delivery system 400 includes a sheath 420 in the delivery handle, a connector member 406 at the distal end of the ICD delivery system 400, and a sheath handle 412 connected to the guide shaft 405, which allows a doctor or surgeon to place an ICD device during, for example, a colon resection. The ICD delivery system 400 facilitates the placement of the ICD device by maintaining a small anchor profile during insertion and protecting the expandable sealing mechanism (i.e., an expandable elastomeric balloon) from potential damage when the device is inserted into a stapled anastomosis. This embodiment anchors the open end of the outer protective sheath to the delivery handle to stretch the outer protective sheath to compress the anchor portion of the device. Traction on the connecting member 406 stretches the attached outer protective sheath and compresses the anchor portion of the device. After positioning the device, the outer protective sheath is released from the connecting member 406 and withdrawn through the central lumen of the guide shaft 405. The ICD device is inserted, advanced, and positioned transanally together with the ICD delivery system 400. A water-based lubricant, such as, for example, KY-Jelly, is used to facilitate placement. The anchor portion is positioned 5 cm to 10 cm above the area that needs protection from the flow of stool (e.g., a stoma after rectal cancer surgery) (more proximal in the GI tract). Importantly, the anchor portion of the device is designed to be placed in healthy bowel, not at an area of damaged bowel that needs protection. After positioning the anchor, the outer protective sheath is removed by withdrawing the outer protective sheath using the sheath puller 412. The device is then ready for deployment.
[0195] Fig.11A and 11B Further shown is a portion of the anchoring system engaged with the ICD delivery system 400. For example, Fig.11A and 11B As shown, the anchoring system includes a sleeve body 402 and a sleeve 410 connected to the sleeve body 402, wherein the sleeve 410 is also connected to the handle portion 404 of the ICD delivery system 400. According to one embodiment, the sheath of the ICD delivery system 400 (see, for example Fig. 11C A sheath 420 (shown in FIG. 4 ) is provided at the proximal end and the entire length of the anchoring system or sleeve body 402 and sleeve 410 to protect the sleeve body 402 and sleeve 410 during insertion of the anchoring system into the patient's body, as well as first and second expandable sealing mechanisms (not shown) provided on the sleeve body 402 and foam (not shown) dispersed on the sleeve body 402. A guide shaft 405 attached to a sheath handle 412 is positioned inside the sleeve 410 and sleeve body 402 to push the anchoring system into a suitable position within the anal canal.
[0196] Fig. 11C Shows Fig.11A and 11B FIG. 4 is a partial enlarged cross-sectional view of the proximal end of the ICD delivery system 400. Fig. 11CAs shown, the sheath 420 is disposed at least on the proximal end of the anchoring system or sleeve body 402 and sleeve 410, the proximal end including first and second expandable sealing mechanisms (not shown) and foam (not shown). A guide shaft 405 attached to a sheath handle 412 is positioned inside the sleeve 410 and sleeve body 402 to push the anchoring system into position within the anal canal. Fig. 11C As further shown, the sheath 420 extends to an upper portion 422a and a lower portion 422b, which are attached to a sheath handle 412 so that the sheath 420 can be removed from the anchoring system or the sleeve body 402 and sleeve 410 by pulling the sheath handle 412 in a distal direction. When the sheath handle 412 is pulled in a distal direction, the sheath 420 is removed from the outer surface of the sleeve body 402 and sleeve 410, including the first and second expandable sealing mechanisms (not shown) and the foam (not shown), and is pulled through the lumen of the sleeve body 402 and sleeve 410, and then away from the device. This removal of the sheath 420 typically occurs once the anchoring system is placed in place within the anal canal via the guide shaft 405.
[0197] Fig.11D Shows Fig.11A and 11B FIG. 4 is an enlarged partial cross-sectional view of the distal end or handle portion of the ICD delivery system 400. Fig.11D As shown, the guide shaft 405 is attached to the sheath handle 412, wherein the guide shaft 405 is configured to slide into and out of the sleeve 410 of the anchor system, and the handle portion 404 and connector member 406 at the distal end of the ICD delivery system 400. Fig.11D As further shown, the handle portion 404 is configured to attach (i) to a sleeve 410 of the anchoring system at a proximal end of the handle portion 404 , and (ii) to a connector member 406 at a distal end of the handle portion 404 .
[0198] According to some embodiments, the ICD device is deployed by the following actions: (i) inflating the inflatable sealing mechanism 108, 110 (e.g., inflatable balloon) by injecting a fluid or inflation medium (e.g., saline, mineral oil, and / or a dye-based (e.g., iodine-based) contrast solution) via syringes connected to distal and proximal ports of the device, respectively, (ii) connecting a negative pressure source (e.g., a vacuum source) to the port (e.g., a vacuum port) to anchor the device and / or activate negative pressure, and (iii) withdrawing the handle 306, 412 and guide shaft 303, 405 of the ICD delivery system 300, 400 from the ICD device. According to one embodiment, the dye-based (e.g., iodine-based) contrast solution is used to fill the inflatable sealing mechanism 108, 110 (e.g., inflatable balloon) because the osmotic gradient helps to better maintain the inflatable sealing mechanism 108, 110 (e.g., inflatable balloon) in the inflated form and also allows for radiographic analysis of the anchoring position within the body. According to one embodiment, removal of the ICD device is accomplished by (i) disconnecting the source of negative pressure (e.g., a vacuum source) and releasing the negative pressure or vacuum, (ii) collapsing the inflatable sealing mechanisms 108, 110 (e.g., inflatable balloons) by completely removing fluid via syringes connected to distal and proximal ports of the device, respectively, (iii) injecting a small amount of saline through a port (e.g., a vacuum port) to disrupt the anchoring seal, and (iv) removing the external dressing (discussed in further detail below) and gently pulling the ICD device sleeve until the ICD device is completely removed from the anal verge.
[0199] In some embodiments, there is a releasable, fluid-tight and detachable connector that allows the length of the sleeve outside the body to be removed to allow for easier delivery of the device. In some embodiments, the connector is located 8 inches to 36 inches from the closest sealing mechanism. In other embodiments, the sleeve is directly connected to the outflow bag or is left open 8 inches to 36 inches from the closest sealing mechanism.
[0200] According to some embodiments, the device 100 has a removal system that allows it to be removed as needed. Fluid (e.g., saline) or positive pressure can be delivered along the pressure tube (not shown) and / or the negative pressure lumen 145 to reduce the adhesive forces generated to anchor the device 100. The device 100 can then be safely removed from the patient. In some embodiments, the device 100 is configured with a port so that a fluid (e.g., a saline solution) can be used to penetrate the tube in communication with the foam and separate the sleeve body 102 from the intestinal wall. The fluid can be introduced into the pressure tube (not shown), or the device 100 can have a separate tube extending outside the patient's body to provide irrigation (see also, e.g., Figure 2CThe flushing lumen 144 of the proximal inflatable sealing mechanism 108 is preferably used to perform both negative pressure delivery and flushing. In some embodiments, a flushing system is fluidly connected to the pressure tube, wherein the flushing system introduces fluid into the pressure tube for flushing. Flushing through the tube can be used to wash out abdominal contents that may have leaked around the proximal inflatable sealing mechanism 108 and separate the device 100 from the intestinal wall of the patient. By using one or more of these removal methods, the pull-out force becomes negligible and the device 100 can be removed without damaging surrounding tissue.
[0201] Sightglass adapter
[0202] According to some embodiments, the system includes an ICD scope adapter that can be used in conjunction with the ICD device.The scope adapter allows the ICD device to be inserted and deployed using a sigmoidoscope, endoscope, or colonoscopy scope.
[0203] Fig.15A and 15B An ICD scope adapter according to one embodiment of the present invention is shown. Fig.15A and 15B As shown, the scope adapter 800 includes a body 802, a compression nut 804, a compression sleeve 805, and a compression washer 806. Fig. 15B As further shown, the body 802 includes a plurality of threads 812 configured to engage with a plurality of grooves 814 disposed along an inner surface of the compression nut 804 .
[0204] Fig.16 The embodiment of the present invention is shown along Fig.15A The line 16-16 is intercepted Fig.15A and 15B A cross-sectional view of the scope adapter is shown. Fig.16 As shown, the body 802 of the scope adapter 800 is engaged with the compression nut 804 via a plurality of threads 812 disposed on the body 802, and the plurality of threads are engaged with a plurality of grooves 814 disposed on the compression nut 804. Fig.16 As further shown, the compression sleeve 805 has a sliding taper 810 that allows the compression sleeve 805 to easily fit inside the body 802. A compression washer 806 is disposed within the compression nut 804 and presses against the compression sleeve 805. Fig.16 In the embodiment of the present invention, the body 802 also includes a recess 820 on each side of the body 802, which allows for connection with a sigmoidoscope, endoscope, or colonoscope, as discussed in more detail below.
[0205] Fig.17 is a schematic diagram of an anchoring system connected to an endoscope via a scope adapter according to some embodiments of the present invention. Fig.17As shown in the embodiment of the present invention, an anchoring system 1000 is provided, which includes a first expandable sealing mechanism 1008 disposed at the proximal end of a sleeve body 1002, a second expandable sealing mechanism 1010 disposed at the distal end of the sleeve body 1002, an open-cell foam 1020 disposed on the outer surface of the sleeve body 1002, and a sleeve 1016 in fluid communication with the distal end of the sleeve body 1002. The anchoring system 1000 also includes a plurality of connectors or ports 1024, 1026 and 1028 for providing fluid or inflation media (e.g., saline, mineral oil and / or dye-based (e.g., iodine-based) contrast solutions) to expand the first and second expandable sealing mechanisms 1008, 1010, irrigation, drugs (e.g., antibiotics, anti-inflammatory drugs, or chemotherapeutic agents), and / or radiological contrast agents, as described above with respect to Figure 1A As discussed. Fig.17 As further shown, Fig.15A , 15B The endoscope adapter 800 of the embodiment of 16 is configured to connect an end (ie, a distal end) of the anchoring system 1000 to the endoscope 1200 .
[0206] Fig.18 According to an embodiment of the present invention, Fig.17 The line 18-18 is intercepted Fig.17 A cross-sectional view of the scope adapter is shown. Fig.18 As shown, Fig.17 The sleeve 1016 of the anchoring system 1000 is attached to the scope adapter 800 via a quick connector latching point or fitting that includes an extension member 1100 having a latching member 1102 disposed on the sleeve 1016 that latches with a recess 820 disposed on each side of the body 802 of the scope adapter 800. According to one embodiment, the ICD scope adapter 800 is attached to the quick connector latching point or fitting of the ICD device (e.g., the anchoring system 1000) such that the ICD device is attached to the ICD scope adapter 800 by sliding over the shaft of an endoscope 1200 (or sigmoidoscope or colonoscopy scope) (see, e.g., FIG. 1 ). Fig.18 The endoscope-shaft interface 1120 of the endoscope is then positioned according to physician needs or preferences. When positioned in the desired position, the body 802 of the ICD scope adapter 800 is held firmly with one hand while the compression nut 804 is turned in a clockwise direction with the other hand. The compression nut 804 of the ICD scope adapter 800 is turned until the compression sleeve 805 clamps the outside of the shaft of the endoscope 1200 (or sigmoidoscope or colonoscopy scope) to provide a non-slip connection (see, e.g., Fig.18 Mirror-axis interface 1120).
[0207] According to one embodiment, an ICD device (e.g., Fig.17 If the provider wishes to advance the end of the endoscope 1200 more distally or retract it more proximally, the provider simply loosens the compression nut 804 of the ICD scope adapter 800 and can adjust the position of the compression sleeve 805 of the ICD scope adapter 800 to the desired position along the endoscope 1200 and then retighten.
[0208] ICD Dressing
[0209] According to some embodiments, the system includes an ICD retention dressing that provides an additional means of securing the ICD device to the patient and minimizing migration. The ICD retention dressing may be provided in an easy-to-open cold seal bag.
[0210] Figures 19A-19H FIG. 2 shows an ICD retaining dressing according to an embodiment of the present invention. Fig.19A As shown, ICD retention dressing 1200 includes a retention dressing 1204 and two retention dressing strips 1206A, 1206B. The retention dressing 1204 and the retention dressing strips 1206A, 1206B are pre-cut on a carrier sheet 1202, which may be made of, for example, mylar, and also include a pre-cut removable backing paper to aid in attachment (as discussed in further detail below). Fig.19A As further shown, retention dressing 1204 includes a body portion 1205 , a middle portion 1212 having a circular opening 1215 , a first leg member 1208 , and a second leg member 1210 .
[0211] Figures 19B-19H The embodiment of the present invention is shown Fig.19A The method of attaching an ICD retaining dressing to an anchoring system is shown. In a first step, as Fig.19B As shown, the ICD retaining dressing 1200 including the retaining dressing 1204 and the two retaining dressing strips 1206A, 1206B is removed from the carrier sheet 1202. In a second step, as shown in FIG. Fig.19C As shown, the first pre-cut removable liner 1220 is removed from the middle portion 1212 of the retention dressing 1204 including the circular opening 1215. Thereafter, in a third step, as shown Fig.19D As shown, two retention dressing strips 1206A, 1206B are positioned within the circular opening 1215 of the middle portion 1212 of the retention dressing 1204. In the fourth step, as shown in FIG. Fig.19EAs shown, the second and third pre-cut removable liners 1216A, 1216B are removed from the ends of the two retaining dressing strips 1206A, 1206B, respectively, so as to attach the two retaining dressing strips 1206A, 1206B to the circular opening 1215 of the middle portion 1212. In the fifth step, as shown in FIG. Fig.19F As shown, the fourth and fifth pre-cut removable liner layers 1226A, 1216B are removed from the sides of the two retaining dressing strips 1206A, 1206B, respectively. Fig.19F As shown, the anchoring device or ICD device 1260 is inserted into the circular opening 1215 of the middle portion 1212 of the retaining dressing 1204 so that the end 1250 of the anchoring device or ICD device 1260 is positioned between the two retaining dressing strips 1206A, 1206B. In the sixth step, as shown in FIG. Figure 19G As shown, two retaining dressing strips 1206A, 1206B are wrapped (e.g., spirally wrapped) around the anchoring device or ICD device 1260. The two opposing retaining dressing strips 1206A, 1206B are spirally wrapped and bonded to the anchoring device or ICD device 1260, particularly the sleeve body of the anchoring device or ICD device 1260, so as to secure the anchoring device or ICD device 1260 to the ICD retaining dressing 1200. Finally, in the final step, as shown in FIG. Fig.19H 1204, and the eighth pre-cut removable liner 1205A is removed from the main body portion 1205 of the retention dressing 1204. At this point, the ICD retention dressing 1200 is applied to the patient's inner buttocks via the main body portion 1205 of the retention dressing 1204 and wrapped around the patient to the lower back and anterior groin area. According to one embodiment, the first leg member 1208 and the second leg member 1210 of the retention dressing 1204 are attached to the patient's front side and arranged on both sides of the anterior groin area thereof, while the middle portion 1212 of the retention dressing 1204 having the circular opening 1215 is positioned around the patient's anus.
[0212] According to one embodiment, the material of the ICD retaining dressing is a biocompatible transparent polyurethane film laminated to a spunlace polyester nonwoven fabric, such that the inner surface is coated with a medical grade pressure sensitive acrylic adhesive and provided on a removable paper liner. The medical grade adhesive may be designed for extended wear skin contact use. In addition, the outer spunlace polyester surface may have a thin non-absorbent coating.
[0213] According to another embodiment, the ICD retention dressing is designed to be attached to the skin and worn by a patient for up to at least 14 days.
[0214] ICD device column strength
[0215] According to some embodiments of the present invention, the ability of the anchoring portion of the ICD device to move forward against external resistance is due to (i) the column strength of the diameter, wall thickness, shape, and material type of the outer sleeve, and (ii) the internal support provided by the diameter, wall thickness, shape, and material type of the internal support member (i.e., the guide shaft). In this case, the relevant yield strength for column buckling is the compressive yield strength of the selected material. The column strength of the outer sleeve can be calculated and customized by appropriately selecting the material type and material properties. In addition to the column strength of the outer sleeve, the internal support (guide shaft) prevents axial and lateral collapse and buckling. The added support allows the use of softer and / or thinner wall materials while providing the strength required to overcome the forward resistance required to insert the device.
[0216] According to some embodiments, the outer sleeve (eg, sleeve 116) has a column strength of 4.0 lbs when supported by the inner support member. According to another embodiment, the column strength may be in the range of 3.0 lbs to 6.0 lbs.
[0217] According to some embodiments, the outer sleeve (e.g., sleeve 116) has a wall thickness of 0.035 inches, although the wall thickness can range from 0.020 inches to 0.080 inches in thickness. According to one embodiment, the outer sleeve has a hardness of Shore 60A durometer, although the hardness can range from Shore 40A to Shore 90A.
[0218] According to some embodiments, the inner support member (guide shaft) has a diameter of 0.500 inches, although the diameter can be in the range of 0.375 inches to 0.625 inches. According to one embodiment, the inner support member has a wall thickness of 0.06 inches, although the wall thickness can be in the range of 0.020 inches to 0.080 inches in thickness. According to one embodiment, the inner support member material has a stiffness of 1600 MPa tensile E modulus, although the stiffness can be in the range of 220 MPa to 2500 MPa tensile E modulus.
[0219] Embodiments of the invention described herein provide an anchoring device designed to have a redundant fecal bypass even if negative pressure fails because the inflatable sealing mechanism (e.g., a balloon) will still block most of the fecal flow and the device will remain in place with external fixation due to the column strength of the sleeve and / or sleeve body. Additionally, use of the device on an endoscope requires that the sleeve and / or sleeve body will not collapse in order for the device to be pushed into the patient. Therefore, to ensure that a delivery system using a scope adapter will work, a certain column strength is necessary.
[0220] Other Uses
[0221] Embodiments of the invention described herein can be used outside of protection of damaged intestine or anastomosis protection. For example, the disclosed devices and methods can also be used for continence control in settings such as intensive care units. In these settings, fecal contamination of the perineum can cause significant skin irritation and rupture. Existing continence control devices for diverting fecal flow into a collection bag often lead to complications such as fecal leakage, displacement of the fecal tube, and erosion into the intestinal wall. In contrast, the devices and methods described herein can anchor the fecal collection sheath / sleeve in the patient's rectum with an anchoring mechanism that is non-traumatic, isolated from the leak seal, not easily displaced, and easily reversible. The anchoring method described herein can also be used to fix other sheaths / sleeves or drug delivery devices in the intestine. For example, the technology can be used to anchor a limited absorption sheath / sleeve design for treating metabolic disorders, diabetes or obesity. Special sheaths / sleeves for eluting drugs can also be anchored using the technology. For example, a sheath / sleeve attached to the anchor device described herein can contain a controlled release anti-inflammatory drug to treat inflammatory bowel disease. In addition, as described above, a second anchoring element can be placed distally to form a sealed space between the treated intestinal segment, the two anchoring elements and the sleeve. This space can be filled with a therapeutic solution, such as an antibiotic, an anti-inflammatory drug, or a chemotherapeutic agent for cancer. This allows controlled local delivery to the intestinal wall segment isolated between the two anchoring elements. In addition, as previously described, the sleeve can be anchored, which can help divert fluid from damaged segments of the intestine (e.g., perforations in the intestine, ischemic intestines, intestines bruised by blunt trauma, or inflamed or dilated intestines, such as in the case of inflammatory bowel disease).
[0222] Other aspects of the disclosure are provided by the subject matter of the following clauses.
[0223] An anchoring system comprises: a sleeve having an inner surface defining a lumen; a first expandable sealing mechanism disposed along a proximal end of the sleeve; a second expandable sealing mechanism disposed along the proximal end of the sleeve; and an open-cell foam disposed on an outer surface of the sleeve, wherein expansion of the first and second expandable sealing mechanisms and application of negative pressure to the anchoring system results in a seal formed between the first and second expandable sealing mechanisms, the outer surface of the sleeve, and the inner surface of the tissue cavity.
[0224] The anchoring system according to any preceding clause, further comprising a sleeve body, wherein (i) the first expandable sealing mechanism is disposed at a proximal end of the sleeve body, and (ii) the second expandable sealing mechanism is disposed at a distal end of the sleeve body.
[0225] An anchoring system according to any preceding clause, wherein the distal end of the sleeve body is connected to the proximal end of the sleeve.
[0226] An anchoring system according to any preceding clause, wherein the sleeve body is coextensive with the sleeve.
[0227] An anchoring system according to any preceding clause, wherein the sleeve body is provided on the proximal end of the sleeve.
[0228] An anchoring system according to any preceding clause, wherein the sleeve comprises a plurality of fluid lumens.
[0229] An anchoring system according to any preceding clause, wherein the plurality of fluid lumens comprises one or more of: (i) a distal fluid lumen to provide fluid to the first inflatable sealing mechanism, (ii) a proximal fluid lumen to provide fluid to the second inflatable sealing mechanism, (iii) an irrigation lumen, (iv) a contrast dye lumen, and (v) a negative pressure lumen.
[0230] An anchoring system according to any preceding clause, wherein application of negative pressure generates a friction force resisting displacement of the sleeve.
[0231] An anchoring system according to any preceding clause, wherein application of negative pressure causes the open-cell foam disposed on the outer surface of the sleeve to contact the inner surface of the tissue cavity, thereby generating a friction force that resists displacement of the sleeve.
[0232] An anchoring system according to any preceding clause, wherein the first and second inflatable sealing mechanisms are inflated by providing an incompressible fluid to inflate the first and second inflatable sealing mechanisms.
[0233] An anchoring system according to any preceding clause, wherein the incompressible fluid is at least one of saline, mineral oil and a dye-based contrast solution.
[0234] The anchoring system according to any preceding clause, wherein once expanded, the first and second expandable sealing mechanisms form a substantially gas- and fluid-tight seal with the inner surface of the tissue cavity.
[0235] An anchoring system according to any preceding clause, wherein the sleeve protects the inner surface of the tissue cavity from fecal flow.
[0236] The anchoring system of any preceding clause, wherein the lumen has a diameter of between about 1 cm and about 6 cm.
[0237] The anchoring system of any preceding clause, wherein the sleeve comprises a flexible material having a Shore A hardness of between about 20A and about 70A.
[0238] An anchoring system according to any preceding clause, wherein the open cell foam comprises polyvinyl alcohol, polyurethane foam or other synthetic polymers.
[0239] An anchoring system according to any preceding clause, wherein the open cell foam has a tensile strength of at least 50 kPa.
[0240] An anchoring system according to any preceding clause, wherein the open cell foam has a thickness of between 2 mm and 150 mm.
[0241] An anchoring system according to any preceding clause, wherein the first and second expandable sealing mechanisms each comprise an expandable elastomeric balloon.
[0242] An anchoring system according to any preceding clause, wherein the first and second expandable sealing mechanisms each comprise a plurality of expandable elastomeric balloons.
[0243] An anchoring system according to any preceding clause, wherein (i) the first expandable sealing mechanism comprises a single expandable elastomeric balloon, and (ii) the second expandable sealing mechanism comprises a plurality of expandable elastomeric balloons.
[0244] An anchoring system according to any preceding clause, wherein the first and second expandable sealing mechanisms have an annular diameter greater than an annular diameter of the open cell foam dispersed around the sleeve.
[0245] The anchoring system of any preceding clause, wherein the sleeve has a column strength of approximately 3.0 lbs to 6.0 lbs.
[0246] The anchoring system according to any preceding clause, further comprising a collection bag disposed at a distal end of the sleeve and configured to manage intestinal contents passing from the anchoring system.
[0247] An anchoring system according to any preceding clause, further comprising a retaining dressing to attach the anchoring system to the skin.
[0248] The anchoring system according to any preceding clause, further comprising an extension tube connected to the distal end of the sleeve, the extension tube being configured to extend the anchoring system outside the patient's body.
[0249] The anchoring system of any preceding clause, further comprising a scope adapter configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope.
[0250] An anchoring system according to any preceding clause, wherein the scope adapter comprises a body, a compression nut, a compression sleeve and a compression washer.
[0251] An anchoring system according to any preceding clause, wherein the body comprises a plurality of threads configured to engage with a plurality of grooves provided along an inner surface of the compression nut.
[0252] The anchoring system of any preceding clause, further comprising a connector latch point configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope via the scope adapter.
[0253] The anchoring system according to any preceding clause, further comprising a negative pressure source, wherein negative pressure is applied to the anchoring system by the negative pressure source to maintain one of a constant negative pressure or a variable negative pressure at a level between -50 mmHg and -200 mmHg.
[0254] The anchoring system according to any preceding clause, further comprising a negative pressure lumen configured to provide negative pressure to the sleeve.
[0255] An anchoring system according to any preceding clause, wherein the sleeve has a length allowing it to extend outside of the tissue cavity.
[0256] An anchoring system according to any preceding clause, wherein the lumen and the first and second expandable sealing mechanisms are compressible by normal peristaltic forces of the patient's intestine.
[0257] An anchoring system according to any preceding clause, wherein the sleeve has a length of between about 3 cm and about 25 cm.
[0258] An anchoring system according to any preceding clause, wherein the sleeve and / or the sleeve body is composed of one or more of silicone, polyurethane, thermoplastic elastomer, rubber, rubber-like material or other polymers.
[0259] An anchoring system according to any preceding clause, wherein the sleeve and the sleeve body are formed from one continuous tubular extrusion.
[0260] An anchoring system according to any of the preceding clauses, wherein the proximal end of the sleeve is in sealing fluid communication with the distal end of the sleeve body and the second expandable sealing mechanism and extends distally thereof, wherein the proximal end of the sleeve extending distally of the distal end of the sleeve body is configured to cover and protect damaged areas of tissue of the tissue cavity from contents flowing through the lumen of the sleeve and the sleeve body.
[0261] A delivery system comprising: an outer protective sheath enclosing an anchoring system according to any preceding clause; a handle; a guide shaft; and a sheath puller, wherein the anchoring system is configured to be pushed into position by advancing the guide shaft into the intestine of a patient.
[0262] A delivery system includes: a handle; a guide shaft connected to the handle; an outer protective sheath configured to cover and protect a proximal end of an anchoring system having at least one expandable sealing mechanism; and a sheath puller attached to the outer protective sheath.
[0263] A delivery system according to any preceding clause, wherein the outer protective sheath is disposed within the central lumen of the guide shaft and is configured to extend from the central lumen to cover and protect the proximal end of the anchoring system having the at least one expandable sealing mechanism.
[0264] A delivery system according to any preceding clause, for use with an anchoring system having a sleeve having a post strength high enough to prevent collapse of the system during insertion through the delivery system.
[0265] A method for anchoring a sleeve in a tissue cavity, the sleeve having an outer surface, the outer surface including foam for contacting an inner wall of the tissue cavity, and an expandable sealing mechanism for isolating a portion of the tissue cavity adjacent to the sleeve from the remainder of the tissue cavity, the method comprising: inserting the sleeve into the tissue cavity; inflating the expandable sealing mechanism to create a seal between the expandable sealing mechanism and the inner wall of the tissue cavity; and applying negative pressure to an area between the outer surface of the sleeve and the inner surface of the isolated portion of the tissue cavity to create friction between the foam of the sleeve and the inner surface of the tissue cavity.
[0266] A method according to any preceding clause, wherein the step of inflating the inflatable sealing means is performed by injecting an inflation medium into the inflatable sealing means.
[0267] A method according to any preceding clause, wherein the inflation medium comprises at least one of saline, mineral oil and / or a dye-based contrast solution.
[0268] A method according to any preceding clause, wherein the step of inserting the sleeve into the tissue cavity is performed using a delivery system comprising a handle and a guide shaft.
[0269] The method according to any preceding clause, further comprising the step of withdrawing the handle and the guide shaft of the delivery system from the sleeve.
[0270] The method of any preceding clause, further comprising removing the sleeve from the tissue cavity by: releasing the negative pressure; collapsing the expandable sealing mechanism; and injecting a volume of saline through a port to break the seal.
[0271] A device according to any preceding clause, which utilizes two redundant methods of anchoring within the intestine, wherein (i) the first method is to utilize a negative pressure based friction anchor as described in any preceding clause, and (ii) the second method is to secure an external portion of the device to the skin, wherein the sleeve has a column strength such that even if there is a failure in the first method of anchoring, the column strength is high enough to maintain the anchor portion of the device in the proper position; and such that if there is a failure in the second method, the first method of securement is sufficient to maintain the anchor portion of the device in the proper position.
[0272] A method of inserting an anchoring system according to any preceding clause, the method using an endoscope connected to the anchoring system.
[0273] A method according to any preceding clause, wherein the anchoring system is inserted using direct visualization via the endoscope.
[0274] An anchoring system comprises: a sleeve having an inner surface defining a lumen; a first inflatable sealing mechanism disposed along a proximal end of the sleeve; a second inflatable sealing mechanism disposed along the proximal end of the sleeve; and an air-conducting rough surface material disposed on an outer surface of the sleeve, wherein (i) expansion of the first and second inflatable sealing mechanisms and (ii) application of negative pressure to the anchoring system results in a seal formed between the first and second inflatable sealing mechanisms, the outer surface of the sleeve, and the inner surface of the tissue cavity.
[0275] The anchoring system according to any preceding clause, further comprising a sleeve body, wherein (i) the first expandable sealing mechanism is disposed at a proximal end of the sleeve body, and (ii) the second expandable sealing mechanism is disposed at a distal end of the sleeve body.
[0276] An anchoring system according to any preceding clause, wherein the air conducting rough surface material is at least one of a stacked mesh matrix, a honeycomb grid of interconnected channels, a gauze, a fabric or a three-dimensional woven material.
[0277] An anchoring system according to any preceding clause, wherein the distal end of the sleeve body is connected to the proximal end of the sleeve.
[0278] An anchoring system according to any preceding clause, wherein the sleeve body is coextensive with the sleeve.
[0279] An anchoring system according to any preceding clause, wherein the sleeve body is provided on the proximal end of the sleeve.
[0280] An anchoring system according to any preceding clause, wherein the sleeve comprises a plurality of fluid lumens.
[0281] An anchoring system according to any preceding clause, wherein the plurality of fluid lumens comprises one or more of: (i) a distal fluid lumen to provide fluid to the first inflatable sealing mechanism, (ii) a proximal fluid lumen to provide fluid to the second inflatable sealing mechanism, (iii) an irrigation lumen, (iv) a contrast dye lumen, and (v) a negative pressure lumen.
[0282] An anchoring system according to any preceding clause, wherein application of negative pressure generates a friction force resisting displacement of the sleeve.
[0283] An anchoring system according to any preceding clause, wherein application of negative pressure causes the air conducting rough surface material disposed on the outer surface of the sleeve to contact the inner surface of the tissue cavity, thereby generating a friction force resisting displacement of the sleeve.
[0284] An anchoring system according to any preceding clause, wherein the first and second inflatable sealing mechanisms are inflated by providing an incompressible fluid to inflate the first and second inflatable sealing mechanisms.
[0285] An anchoring system according to any preceding clause, wherein the incompressible fluid is at least one of saline, mineral oil and a dye-based contrast solution.
[0286] The anchoring system according to any preceding clause, wherein once expanded, the first and second expandable sealing mechanisms form a substantially gas- and fluid-tight seal with the inner surface of the tissue cavity.
[0287] An anchoring system according to any preceding clause, wherein the sleeve protects the inner surface of the tissue cavity from fecal flow.
[0288] The anchoring system of any preceding clause, wherein the lumen has a diameter of between about 1 cm and about 6 cm.
[0289] The anchoring system of any preceding clause, wherein the sleeve comprises a flexible material having a Shore A hardness of between about 20A and about 70A.
[0290] An anchoring system according to any preceding clause, wherein the air conductive rough surface material has a tensile strength of at least 50 kPa.
[0291] An anchoring system according to any preceding clause, wherein the air conductive rough surface material has a thickness of between 2mm and 150mm.
[0292] An anchoring system according to any preceding clause, wherein the first and second expandable sealing mechanisms each comprise an expandable elastomeric balloon.
[0293] An anchoring system according to any preceding clause, wherein the first and second expandable sealing mechanisms each comprise a plurality of expandable elastomeric balloons.
[0294] An anchoring system according to any preceding clause, wherein (i) the first expandable sealing mechanism comprises a single expandable elastomeric balloon, and (ii) the second expandable sealing mechanism comprises a plurality of expandable elastomeric balloons.
[0295] An anchoring system according to any preceding clause, wherein the first and second expandable sealing mechanisms have an annular diameter that is greater than an annular diameter of the air conducting rough surface material dispersed about the sleeve.
[0296] The anchoring system of any preceding clause, wherein the sleeve has a column strength of approximately 3.0 lbs to 6.0 lbs.
[0297] The anchoring system according to any preceding clause, further comprising a collection bag disposed at a distal end of the sleeve and configured to manage intestinal contents passing from the anchoring system.
[0298] An anchoring system according to any preceding clause, further comprising a retaining dressing to attach the anchoring system to the skin.
[0299] The anchoring system according to any preceding clause, further comprising an extension tube connected to the distal end of the sleeve, the extension tube being configured to extend the anchoring system outside the patient's body.
[0300] The anchoring system of any preceding clause, further comprising a scope adapter configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope.
[0301] An anchoring system according to any preceding clause, wherein the scope adapter comprises a body, a compression nut, a compression sleeve and a compression washer.
[0302] An anchoring system according to any preceding clause, wherein the body comprises a plurality of threads configured to engage with a plurality of grooves provided along an inner surface of the compression nut.
[0303] The anchoring system of any preceding clause, further comprising a connector latch point configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope via the scope adapter.
[0304] The anchoring system according to any preceding clause, further comprising a negative pressure source, wherein negative pressure is applied to the anchoring system by the negative pressure source to maintain one of a constant negative pressure or a variable negative pressure at a level between -50 mmHg and -200 mmHg.
[0305] The anchoring system according to any preceding clause, further comprising a negative pressure lumen configured to provide negative pressure to the sleeve.
[0306] An anchoring system according to any preceding clause, wherein the sleeve has a length allowing it to extend outside of the tissue cavity.
[0307] An anchoring system according to any preceding clause, wherein the lumen and the first and second expandable sealing mechanisms are compressible by normal peristaltic forces of the patient's intestine.
[0308] An anchoring system according to any preceding clause, wherein the sleeve has a length of between about 3 cm and about 25 cm.
[0309] An anchoring system according to any preceding clause, wherein the sleeve and / or the sleeve body is composed of one or more of silicone, polyurethane, thermoplastic elastomer, rubber, rubber-like material or other polymers.
[0310] An anchoring system according to any preceding clause, wherein the sleeve and the sleeve body are formed from one continuous tubular extrusion.
[0311] An anchoring system according to any of the preceding clauses, wherein the proximal end of the sleeve is in sealing fluid communication with the distal end of the sleeve body and the second expandable sealing mechanism and extends distally thereof, wherein the proximal end of the sleeve extending distally of the distal end of the sleeve body is configured to cover and protect damaged areas of tissue of the tissue cavity from contents flowing through the lumen of the sleeve and the sleeve body.
[0312] An anchoring system configured to be anchored within a patient's intestine, the anchoring device comprising: a sleeve configured to be positioned within the patient's intestine; an external portion configured to extend outside the patient's intestine; and two redundant methods of anchoring the device within the intestine, wherein a first method of anchoring the device utilizes a negative pressure-based system that applies negative pressure to the device to generate friction that resists displacement of the sleeve of the device from the intestine, wherein a second method of anchoring the device secures the external portion of the device to the patient's skin, and wherein at least one of the following features is present: (i) the column strength of the sleeve is high enough to hold the device in place even if there is a failure in the first method of anchoring, or (ii) the first method of anchoring is sufficient to hold the device in place even if there is a failure in the second method of anchoring.
[0313] An anchoring system according to any of the preceding clauses, further comprising a redundant third method of anchoring the device, wherein the third method of anchoring utilizes first and second inflatable sealing mechanisms, wherein expansion of the first and second inflatable sealing mechanisms causes a seal to be formed between the first and second inflatable sealing mechanisms and the inner surface of the tissue cavity, wherein the third method of anchoring is sufficient to maintain the device in place even if there is a failure in the first method of anchoring and / or the second method of anchoring.
[0314] The following documents are incorporated herein by reference:
[0315] Morks, AN, Havenga, K., Ploeg, RJ, “Can intraluminal devices prevent or reduce colorectal anastomotic leakage: A review,” World J. Gastroenterol., 2011; 17(40): 4461-4469.
[0316] D' Urso, A., Komen, N., Lefevre, JH, “Intraluminal flexible sheath for the protection of low anastomosis after anterior resection: results from a First-In-Human trial on 15 patients,” Surg. Endosc., 2019.
[0317] Kim, J.H., Kim, S., Jung, S.H., “Fecal diverting device for thesubstitution of defunctioning stoma: preliminary clinical study,” Surg.Endosc., 2019; 33(1): 333-340。
[0318] Reshef, A., Ben-Arie, G., Pinsk, I., “Protection of colorectalanastomosis with an intraluminal bypass device for patients undergoing anelective anterior resection: a pilot study,” Tech, in Coloproctology, 2019;23(6): 565-571。
[0319] Kang, S.I., Kim, S.H., Jung, S.H., Kim, J.H., “The effectiveness of afecal diverting device for prevention of septic complications in a dog modelof ischemic bowel anastomosis,” Asian J. Surg., 2020; 43: 251-256 (availableonline April 11, 2019)。
[0320] Bakker, I S., Morks, A.N., Ten Cate Hoedemaker, H.O., et al.,“Randomized clinical trial of biodegradeable intraluminal sheath to preventanastomotic leak after stapled colorectal anastomosis,” BJS Society Ltd.,2017。
[0321] The embodiments shown and discussed in this specification are intended only to teach those skilled in the art how to make and use the present invention. When describing the embodiments of the present invention, specific terms are used for the sake of clarity. However, the present invention is not intended to be limited to the specific terms so selected. Without departing from the present invention, as those skilled in the art understand according to the above teachings, the above-mentioned embodiments of the present invention may be modified or changed. Therefore, it should be understood that within the scope of the claims and their equivalents, the present invention may be implemented in a manner different from that specifically described.
Claims
1. An anchoring system, comprising: a sleeve having an inner surface defining a lumen; a first expandable sealing mechanism disposed along a proximal end of the sleeve; a second expandable sealing mechanism disposed along the proximal end of the sleeve; as well as an open-cell foam disposed on an outer surface of the sleeve, Wherein (i) expansion of the first and second expandable sealing mechanisms and (ii) application of negative pressure to the anchoring system results in a seal being formed between the first and second expandable sealing mechanisms, the outer surface of the sleeve, and the inner surface of the tissue cavity.
2. The anchoring system of claim 1, further comprising a sleeve body, wherein (i) the first expandable sealing mechanism is disposed at a proximal end of the sleeve body, and (ii) the second expandable sealing mechanism is disposed at a distal end of the sleeve body.
3. The anchoring system of claim 2, wherein the distal end of the sleeve body is connected to the proximal end of the sleeve.
4. The anchoring system of claim 2, wherein the sleeve body is coextensive with the sleeve.
5. The anchoring system of claim 2, wherein the sleeve body is disposed on the proximal end of the sleeve.
6. The anchoring system of claim 1, wherein the sleeve comprises a plurality of fluid lumens.
7. An anchoring system according to claim 6, wherein the plurality of fluid lumens include one or more of: (i) a distal fluid lumen to provide fluid to the first inflatable sealing mechanism, (ii) a proximal fluid lumen to provide fluid to the second inflatable sealing mechanism, (iii) an irrigation lumen, (iv) a contrast dye lumen, and (v) a negative pressure lumen.
8. The anchoring system of claim 1, wherein application of negative pressure creates a friction force that resists displacement of the sleeve.
9. The anchoring system of claim 8, wherein application of negative pressure causes the open-cell foam disposed on the outer surface of the sleeve to contact the inner surface of the tissue cavity, thereby generating a friction force that resists displacement of the sleeve.
10. The anchoring system of claim 1, wherein the first and second expandable sealing mechanisms are expanded by providing an incompressible fluid to expand the first and second expandable sealing mechanisms.
11. The anchoring system of claim 10, wherein the incompressible fluid is at least one of saline, mineral oil, and a dye-based contrast solution.
12. The anchoring system of claim 10, wherein once expanded, the first and second expandable sealing mechanisms form a substantially gas- and fluid-tight seal with the inner surface of the tissue cavity.
13. The anchoring system of claim 1, wherein the sleeve protects the inner surface of the tissue cavity from fecal flow.
14. The anchoring system of claim 1, wherein the lumen has a diameter between about 1 cm and about 6 cm.
15. The anchoring system of claim 1, wherein the sleeve comprises a flexible material having a Shore A hardness of between about 20A and about 70A.
16. The anchoring system of claim 1, wherein the open cell foam comprises polyvinyl alcohol, polyurethane foam, or other synthetic polymers.
17. The anchoring system of claim 1, wherein the open cell foam has a tensile strength of at least 50 kPa.
18. The anchoring system of claim 1, wherein the open cell foam has a thickness between 2 mm and 150 mm.
19. The anchoring system of claim 1, wherein the first and second expandable sealing mechanisms each comprise an expandable elastomeric balloon.
20. The anchoring system of claim 1, wherein the first and second expandable sealing mechanisms each comprise a plurality of expandable elastomeric balloons.
21. The anchoring system of claim 1, wherein (i) the first expandable sealing mechanism comprises a single expandable elastomeric balloon, and (ii) the second expandable sealing mechanism comprises a plurality of expandable elastomeric balloons.
22. The anchoring system of claim 1, wherein the first and second expandable sealing mechanisms have an annular diameter that is greater than an annular diameter of the open cell foam dispersed about the sleeve.
23. The anchoring system of claim 1, wherein the sleeve has a column strength of approximately 3.0 lbs to 6.0 lbs.
24. The anchoring system of claim 1, further comprising a collection bag disposed at a distal end of the sleeve and configured to manage intestinal contents passing from the anchoring system.
25. The anchoring system of claim 1, further comprising a retention dressing to attach the anchoring system to the skin.
26. The anchoring system of claim 1, further comprising an extension tube connected to a distal end of the sleeve, the extension tube being configured to extend the anchoring system outside the patient's body.
27. The anchoring system of claim 1, further comprising a scope adapter configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope.
28. The anchoring system of claim 27, wherein the scope adapter comprises a body, a compression nut, a compression sleeve, and a compression washer.
29. The anchoring system of claim 28, wherein the body includes a plurality of threads configured to engage with a plurality of grooves disposed along an inner surface of the compression nut.
30. The anchoring system of claim 27, further comprising a connector latch point configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope via the scope adapter.
31. The anchoring system of claim 1, further comprising a negative pressure source, wherein negative pressure is applied to the anchoring system by the negative pressure source to maintain one of a constant negative pressure or a variable negative pressure at a level between -50 mmHg and -200 mmHg.
32. The anchoring system of claim 1, further comprising a negative pressure lumen configured to provide negative pressure to the sleeve.
33. The anchoring system of claim 1, wherein the sleeve has a length that allows it to extend outside of the tissue cavity.
34. The anchoring system of claim 1, wherein the lumen and the first and second expandable sealing mechanisms are compressible by normal peristaltic forces of the patient's intestine.
35. The anchoring system of claim 1, wherein the sleeve has a length of between about 3 cm and about 25 cm.
36. The anchoring system of claim 1 or 2, wherein the sleeve and / or the sleeve body is comprised of one or more of silicone, polyurethane, thermoplastic elastomer, rubber, rubber-like material, or other polymers.
37. The anchoring system of claim 2, wherein said sleeve and said sleeve body are formed from one continuous tubular extrusion.
38. An anchoring system according to claim 2, wherein the proximal end of the sleeve is in sealing fluid communication with the distal end of the sleeve body and the second expandable sealing mechanism and extends distally thereof, wherein the proximal end of the sleeve extending distal to the distal end of the sleeve body is configured to cover and protect damaged areas of tissue of the tissue cavity from the contents flowing through the lumen of the sleeve and the sleeve body.
39. A delivery system comprising: an outer protective sheath enclosing the anchoring system according to claim 1; handle; Guide shaft; as well as Sheath handle, The anchoring system is configured to be pushed into position by advancing the guide shaft into the patient's intestine.
40. A delivery system comprising: handle; a guide shaft connected to the handle; an outer protective sheath configured to cover and protect a proximal end of an anchoring system having at least one expandable sealing mechanism; as well as A sheath handle is attached to the outer protective sheath.
41. The delivery system of claim 40, wherein the outer protective sheath is disposed within a central lumen of the guide shaft and is configured to extend from the central lumen to cover and protect the proximal end of the anchoring system having the at least one expandable sealing mechanism.
42. The delivery system of claim 40 for use with an anchoring system having a sleeve with a post strength high enough to prevent collapse of the system during insertion through the delivery system.
43. A method for anchoring a sleeve in a tissue cavity, the sleeve having an outer surface, the outer surface comprising a foam for contacting an inner wall of the tissue cavity, and an expandable sealing mechanism for isolating a portion of the tissue cavity adjacent the sleeve from a remainder of the tissue cavity, the method comprising: inserting the sleeve into the tissue cavity; inflating the inflatable sealing mechanism to create a seal between the inflatable sealing mechanism and the inner wall of the tissue cavity; as well as Negative pressure is applied to the area between the outer surface of the sleeve and the inner surface of the isolated portion of the tissue cavity to generate friction between the foam of the sleeve and the inner surface of the tissue cavity.
44. The method of claim 43, wherein the step of inflating the inflatable sealing mechanism is performed by injecting an inflation medium into the inflatable sealing mechanism.
45. The method of claim 44, wherein the inflation medium comprises at least one of saline, mineral oil, and / or a dye-based contrast solution.
46. The method of claim 43, wherein the step of inserting the sleeve into the tissue cavity is performed using a delivery system comprising a handle and a guide shaft.
47. The method of claim 46, further comprising the step of withdrawing the handle and the guide shaft of the delivery system from the sleeve.
48. The method of claim 43, further comprising removing the sleeve from the tissue cavity by: releasing the negative pressure; collapsing the expandable sealing mechanism; and A volume of saline is injected through the port to break the seal.
49. The device of claim 1 utilizing two redundant methods of anchoring within the intestine, wherein (i) the first method is utilizing a negative pressure based friction anchor as described in claim 1, and (ii) the second method is securing an external portion of the device to the skin, wherein the sleeve has a column strength that is high enough to hold the anchor portion of the device in place even if there is a failure in the first method of anchoring; and such that the first method of securing is sufficient to hold the anchor portion of the device in place if there is a failure in the second method.
50. A method of inserting the anchoring system of claim 1 using an endoscope connected to the anchoring system.
51. The method of claim 50, wherein the anchoring system is inserted using direct visualization via the endoscope.
52. An anchoring system comprising: a sleeve having an inner surface defining a lumen; a first expandable sealing mechanism disposed along a proximal end of the sleeve; a second expandable sealing mechanism disposed along the proximal end of the sleeve; as well as an air-conducting rough surface material, the air-conducting rough surface material being disposed on an outer surface of the sleeve, Wherein (i) expansion of the first and second expandable sealing mechanisms and (ii) application of negative pressure to the anchoring system results in a seal being formed between the first and second expandable sealing mechanisms, the outer surface of the sleeve, and the inner surface of the tissue cavity.
53. The anchoring system of claim 52, further comprising a sleeve body, wherein (i) the first expandable sealing mechanism is disposed at a proximal end of the sleeve body, and (ii) the second expandable sealing mechanism is disposed at a distal end of the sleeve body.
54. The anchoring system of claim 52, wherein the air conducting rough surface material is at least one of a stacked mesh matrix, a honeycomb grid of interconnected channels, a gauze, a fabric, or a three-dimensional woven material.
55. The anchoring system of claim 53, wherein the distal end of the sleeve body is connected to the proximal end of the sleeve.
56. The anchoring system of claim 53, wherein the sleeve body is coextensive with the sleeve.
57. The anchoring system of claim 53, wherein the sleeve body is disposed on the proximal end of the sleeve.
58. The anchoring system of claim 52, wherein the sleeve comprises a plurality of fluid lumens.
59. An anchoring system according to claim 58, wherein the plurality of fluid lumens include one or more of: (i) a distal fluid lumen to provide fluid to the first inflatable sealing mechanism, (ii) a proximal fluid lumen to provide fluid to the second inflatable sealing mechanism, (iii) an irrigation lumen, (iv) a contrast dye lumen, and (v) a negative pressure lumen.
60. The anchoring system of claim 52, wherein application of negative pressure creates a friction force that resists displacement of the sleeve.
61. The anchoring system of claim 60, wherein application of negative pressure causes the air-conducting rough surface material disposed on the outer surface of the sleeve to contact the inner surface of the tissue cavity, thereby generating a friction force that resists displacement of the sleeve.
62. The anchoring system of claim 52, wherein the first and second expandable sealing mechanisms are expanded by providing an incompressible fluid to expand the first and second expandable sealing mechanisms.
63. The anchoring system of claim 62, wherein the incompressible fluid is at least one of saline, mineral oil, and a dye-based contrast solution.
64. The anchoring system of claim 62, wherein once expanded, said first and second expandable sealing mechanisms form a substantially gas- and fluid-tight seal with said inner surface of said tissue cavity.
65. The anchoring system of claim 52, wherein the sleeve protects the inner surface of the tissue cavity from fecal flow.
66. The anchoring system of claim 52, wherein the lumen has a diameter between about 1 cm and about 6 cm.
67. The anchoring system of claim 52, wherein the sleeve comprises a flexible material having a Shore A hardness of between approximately 20A and approximately 70A.
68. The anchoring system of claim 52, wherein the air conductive rough surface material has a tensile strength of at least 50 kPa.
69. The anchoring system of claim 52, wherein the air conductive rough surface material has a thickness between 2 mm and 150 mm.
70. The anchoring system of claim 52, wherein the first and second expandable sealing mechanisms each comprise an expandable elastomeric balloon.
71. The anchoring system of claim 52, wherein the first and second expandable sealing mechanisms each comprise a plurality of expandable elastomeric balloons.
72. The anchoring system of claim 52, wherein said first and second expandable sealing mechanisms have an annular diameter that is greater than an annular diameter of said air conducting rough surface material dispersed about said sleeve.
73. The anchoring system of claim 52, wherein the sleeve has a column strength of approximately 3.0 lbs to 6.0 lbs.
74. The anchoring system of claim 52, further comprising a collection bag disposed at a distal end of the sleeve and configured to manage intestinal contents passing from the anchoring system.
75. The anchoring system of claim 52, further comprising a retention dressing to attach the anchoring system to the skin.
76. The anchoring system of claim 52, further comprising an extension tube connected to the distal end of the sleeve, the extension tube being configured to extend the anchoring system outside the patient's body.
77. The anchoring system of claim 52, further comprising a scope adapter configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope.
78. The anchoring system of claim 77, wherein the scope adapter comprises a body, a compression nut, a compression sleeve, and a compression washer.
79. The anchoring system of claim 78, wherein the body includes a plurality of threads configured to engage with a plurality of grooves disposed along an inner surface of the compression nut.
80. The anchoring system of claim 77, further comprising a connector latch point configured to connect the sleeve to at least one of an endoscope, a sigmoidoscope, or a colonoscope via the scope adapter.
81. The anchoring system of claim 52, further comprising a negative pressure source, wherein negative pressure is applied to the anchoring system by the negative pressure source to maintain one of a constant negative pressure or a variable negative pressure at a level between -50 mmHg and -200 mmHg.
82. The anchoring system of claim 52, further comprising a negative pressure lumen configured to provide negative pressure to the sleeve.
83. The anchoring system of claim 52, wherein the sleeve has a length that allows it to extend outside of the tissue cavity.
84. The anchoring system of claim 52, wherein the lumen and the first and second expandable sealing mechanisms are compressible by normal peristaltic forces of the patient's intestine.
85. The anchoring system of claim 52, wherein the sleeve has a length of between about 3 cm and about 25 cm.
86. The anchoring system of claims 52 and / or 53, wherein the sleeve and / or the sleeve body is comprised of one or more of silicone, polyurethane, thermoplastic elastomer, rubber, rubber-like material, or other polymers.
87. The anchoring system of claim 53, wherein said sleeve and said sleeve body are comprised of one continuous tubular extrusion.
88. An anchoring system according to claim 53, wherein the proximal end of the sleeve is in sealing fluid communication with the distal end of the sleeve body and the second expandable sealing mechanism and extends distally thereof, wherein the proximal end of the sleeve extending distal to the distal end of the sleeve body is configured to cover and protect damaged areas of tissue of the tissue cavity from the contents flowing through the lumen of the sleeve and the sleeve body.
89. An anchoring device configured to be anchored in the intestine of a patient, the anchoring device comprising: (a) a sleeve configured to be positioned within the intestine of a patient; (b) an external portion configured to extend outside the patient's intestine; as well as (c) two redundant methods of anchoring the device within the intestine, wherein a first method of anchoring the device utilizes a negative pressure based system that applies negative pressure to the device to create a friction force that resists displacement of the sleeve of the device from the intestine, wherein a second method of anchoring the device secures the outer portion of the device to the patient's skin, and wherein at least one of the following features is present: (i) the column strength of the sleeve is sufficiently high to hold the device in place even if there is a failure in the first method of anchoring, or (ii) the first method of anchoring is sufficient to hold the device in place even if there is a failure in the second method of anchoring.
90. The anchoring device of claim 91, further comprising a redundant third method of anchoring the device, wherein the third method of anchoring utilizes first and second inflatable sealing mechanisms, wherein expansion of the first and second inflatable sealing mechanisms causes a seal to be formed between the first and second inflatable sealing mechanisms and the inner surface of the tissue cavity, wherein the third method of anchoring is sufficient to maintain the device in place even if there is a failure in the first method of anchoring and / or the second method of anchoring.
